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Abstract 
The Role of the Colon Epithelium in Visceral Nociception and Gut Motility 
 
 
 
Sarah A. Najjar, PhD 
 
University of Pittsburgh, 2020 
 
 
 
Visceral pain and dysmotility are major symptoms of common gastrointestinal disorders 
like inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). Both of these 
symptoms arise from changes in sensory signaling in the colon; visceral pain results from increased 
excitability of colon extrinsic primary afferent neurons (ExPANs) and disordered motility involves 
changes in neurons of the enteric nervous system (ENS), including the intrinsic primary afferent 
neurons (IPANs) that initiate peristalsis. The colon epithelium is at the forefront of these sensory 
cascades, as it is the first to interact with all luminal contents and contains the machinery to detect 
and send sensory information. However, it is unclear exactly how epithelial cell activity influences 
surrounding afferent neurons in normal and pathological conditions, and this intercellular signaling 
has been difficult to study because of the close association between epithelial and afferent nerve 
endings. Therefore, the goal of my studies was to investigate how selective activation and 
inhibition of colon epithelial cells influences these processes. Using optogenetic tools, I 
demonstrated that specific activation of the colon epithelium initiates action potential firing in 
ExPANs in an ATP-dependent manner. Epithelial-induced ExPAN activation resulted in 
nociceptive behavioral responses. I then showed that inhibition of the epithelium could attenuate 
nociceptive signaling and reduce visceral hypersensitivity in a mouse model of IBD. Lastly, I 
showed that selective activation of the epithelium initiated Ca2+ activity in ENS neurons and 
initiated local colon contractions, which was also dependent on ATP signaling. Additionally, these 
 v 
experiments showed that epithelial activation influenced the frequency of neuronally-mediated 
rhythmic contractions in the colon. Together these results demonstrate for the first time how 
epithelial stimulation, in the absence of any other mechanical or chemical stimuli, initiates 
nociceptive signaling and gut motility. The ability of epithelial inhibition to reduce visceral 
hypersensitivity reveals the potential of targeting the colon epithelium for treatments of pain. 
Understanding the biology of this epithelial-neuronal interface and how it changes in pathological 
conditions will provide valuable insight into why visceral pain is often co-morbid with dysmotility.  
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1.0 Introduction 
Part of 1.0 is reprinted from Trends in Neurosciences, 43(3), Najjar, S.A., Davis, B.M., and 
Albers, K.M. Epithelial-Neuronal Communication in the Colon: Implications for Visceral Pain, 
pg. 170-181, Copyright 2020, with permission from Elsevier.  
1.1 Epithelial-Neuronal Signaling and Visceral Pain 
Visceral hypersensitivity and pain are common debilitating symptoms of inflammatory 
bowel diseases (IBD) and irritable bowel syndrome (IBS). These disorders represent widespread 
health problems, estimated to affect up to 20% of the population (Abdul Rani, Raja Ali, & Lee, 
2016). Effective treatments to control pain and resolve hypersensitivity are lacking. 
Pathophysiological changes associated with IBS and IBD are thought to cause sensitization of 
spinal afferent neurons that innervate the colon, which transmit noxious stimuli to the spinal cord 
and central nervous system (CNS) (Azpiroz et al., 2007; Gold & Gebhart, 2010). Pain research has 
largely focused on injury-evoked changes in spinal afferent and CNS neuron activity, but recent 
studies of skin, bladder, and colon have revealed new regulatory roles for epithelial cells in sensory 
transduction. In skin, epithelial cells (keratinocytes) have been shown to have direct 
communication with epidermal nerve fibers that is sufficient to drive action potential firing and 
nociceptive responses (Baumbauer et al., 2015; Moore et al., 2013; Pang et al., 2015). 
Augmentation of keratinocyte-neural signaling may also occur under inflammatory conditions 
(Kohda, Koga, Uchi, Urabe, & Furue, 2002; Shi et al., 2011; I. S. Song et al., 2000). The bladder 
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epithelium (urothelium) not only serves a barrier function but also has an active role in 
mechanotransduction via release of neuroactive substances such as ATP, acetylcholine, and nitric 
oxide (Winder, Tobin, Zupancic, & Romih, 2014). This release is increased in models of bladder 
inflammation and cystitis (Sun, Keay, De Deyne, & Chai, 2001).  
In the context of the colon, changes in epithelial structure and permeability are common in 
IBD (i.e., ulcerative colitis, Crohn’s disease). In active disease a compromised epithelium allows 
infiltration of bacteria, which provokes inflammatory immune cell responses (Peterson & Artis, 
2014; Roda et al., 2010). Activated immune cells (e.g., macrophages and mast cells) release 
cytokines and neuroactivators that can affect primary afferent function and result in pain (Akbar, 
Walters, & Ghosh, 2009; Sharkey & Kroese, 2001). Biopsies of colon from IBD patients with pain 
often exhibit inflammation (Akbar et al., 2009). However, pain is reported by some patients with 
no evidence of inflammation or epithelial damage (Bielefeldt, Davis, & Binion, 2009). This finding 
and other preclinical studies suggest that epithelial regulation of sensory afferent activity may have 
a more significant role in pain signaling than previously thought and that subtle changes in 
epithelial function could lead to persistent pain. In support of this concept, several studies have 
shown that the intestinal epithelium produces and releases neurotransmitters such as ATP 
(Burnstock, 2001), glutamate (Uehara et al., 2006), serotonin (5-HT) (Gershon, 2013) and 
acetylcholine (ACh) (Klapproth et al., 1997), which act on colon nociceptive neurons. Data in the 
following chapters show that channelrhodopsin (ChR2)-mediated selective activation of the colon 
epithelium is sufficient to evoke action potential firing in ExPANs and a pain-related visceromotor 
response (Makadia et al., 2018). Thus, the epithelium alone, in the absence of applied mechanical, 
chemical or thermal stimuli, can initiate sensory neuron activity and pain-like behavior. At the 
anatomical level, studies have indicated direct synaptic communication between specialized colon 
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epithelial cells and surrounding neurons, providing a direct means of communication (Bellono et 
al., 2017; Bohorquez et al., 2015). Taken together, these observations indicate that with respect to 
structure and function, epithelial cells share many of the properties associated with neurons.  
The first part of this introduction will summarize what is known about extrinsic primary 
afferent neurons (ExPANs) that innervate the colon and how they convey sensory information. 
The different cell types that make up the colon epithelium will be described, with a focus on 
enteroendocrine cells (EECs) and their role in sensory signaling. The chemical mechanisms of 
epithelial-neuronal communication in the colon are also discussed, with emphases on how these 
neurotransmitter systems are altered in colon inflammation and visceral pain disorders such as IBS 
and IBD. 
1.2 Anatomical and Functional Organization of Colon Epithelial-Neuronal Communication 
1.2.1  Extrinsic Sensory Afferents that Innervate the Colon 
Colon function is coordinated by intrinsic and extrinsic subpopulations of neurons. The 
colon receives extrinsic innervation from autonomic and sensory pathways (Brierley, Hibberd, & 
Spencer, 2018). Extrinsic primary afferent neurons (ExPANs) convey sensory information from 
the colon to the central nervous system. They are the first in a chain of neurons that give rise to 
conscious sensations of pain, bloating, fullness and urgency (Brierley et al., 2018). ExPAN somata 
are in dorsal root ganglia (DRG) at thoracolumbar and lumbosacral spinal levels. Thoracolumbar 
afferents project to the colon via the splanchnic nerve and lumbosacral afferents project via the 
pelvic nerve (Brookes, Spencer, Costa, & Zagorodnyuk, 2013). The vagus nerve is a third source 
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of sensory innervation; vagal afferents that project to the colon have cell bodies in the nodose 
ganglion (Brookes et al., 2013). Single-unit electrophysiological recordings made in rodent ex vivo 
preparations have revealed five main classes of ExPANs, defined by their functional properties: 
muscular afferents, which respond to stretching of the colon, mucosal afferents, which respond to 
light distortion of the mucosa, muscular/mucosal afferents, which respond to stretch as well as 
light distortion of the mucosa, and vascular afferents, which respond to focal probing of the colon 
wall (serosal afferents) or mesentery (mesenteric afferents) (Brierley, Jones, Gebhart, & 
Blackshaw, 2004; Brookes et al., 2013). Muscular afferents include both low-threshold 
mechanosensors with a slowly adapting response to low-intensity stretch stimuli and high 
threshold fibers with response properties associated with dedicated nociceptors (Brierley et al., 
2004; Hughes et al., 2009; S. A. Malin, Christianson, Bielefeldt, & Davis, 2009). The low-
threshold fibers are thought to respond to physiological distension induced by the passing of fecal 
matter. Mucosal afferents are also low-threshold responders and thought to participate in detecting 
luminal contents as part of defecatory reflexes (Brierley et al., 2018). In contrast, vascular afferents 
are high-threshold mechanosensors and display an adapting response to noxious stimuli, making 
them likely to transmit mechanically-induced pain stimuli (Brierley et al., 2004; Brierley et al., 
2008). Mechanically insensitive afferents or “silent afferents” represent a fifth class of ExPANs 
that respond to chemical stimuli and, after activation by inflammatory mediators, to mechanical 
stimuli (Feng & Gebhart, 2011). These five major classes of ExPANs have been demonstrated in 
both rodent and human (J. R. F. Hockley, Smith, & Bulmer, 2018).  
The classification of ExPANs continues to be updated as more advanced techniques 
become available. A recent study using single-cell RNAseq analyses proposed distinct classes of 
ExPANs based on molecular profiles (J. R. F. Hockley, Taylor, et al., 2018). These included 
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peptidergic, non-peptidergic, and neurofilament-positive populations at both thoracolumbar and 
lumbosacral levels. This study also identified neurotransmitter receptors expressed across these 
populations. Ongoing molecular and functional studies aim to reveal the signaling mechanisms of 
these ExPAN classes and their role in visceral pain. 
1.2.2  Colon Epithelial Cell Types 
Epithelial cells that line the small and large intestine form a simple columnar epithelium 
with two major functions: absorbing nutrients and water and forming a protective barrier (Figure 
1). Epithelial morphology (i.e., number of villi vs. crypts) and secretory cell populations vary along 
the GI tract (Wong, Vanhove, & Watnick, 2016). This review focuses on the colon epithelium, 
partly because most studies of IBD and IBS in humans examine colon biopsies. Additionally, 
measures and outcomes of most animal models of visceral pain target the colon epithelium and 
ExPANs. Most colon epithelial cells are absorptive enterocytes, with remaining types having 
secretory functions. Secretory cell types include goblet cells that secrete mucus for lubrication, tuft 
cells (also known as brush cells) that secrete opioids and immune mediators (Gerbe & Jay, 2016), 
and enteroendocrine cells (EECs) that secrete hormones and peptides (Leushacke & Barker, 2014). 
There are over 10 types of EECs. Most prevalent in the human and mouse colon are L-cells, which 
express peptide YY (PYY) and glucagon-like peptides 1 and 2 (GLP-1 and GLP-2), and 
enterochromaffin cells, which release serotonin (5-HT) (Gunawardene, Corfe, & Staton, 2011). 
The mouse colon also contains a small number of I-cells that express cholecystokinin (CCK) 
(Egerod et al., 2012) and the human colon contains a small proportion of somatostatin-expressing 
D-cells (Sjolund, Sanden, Hakanson, & Sundler, 1983).  
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Although EECs comprise about 1% of the epithelium, they are the most likely cell type to 
participate in epithelial-neuronal communication in the colon. EECs function as endocrine 
regulators; they sense luminal content and release hormones that regulate secretion, motility and 
satiety signals (Janssen & Depoortere, 2013). EECs express many receptors typically found on 
afferent neurons, e.g., taste receptors that sense glucose, amino acids and fatty acids (Latorre, 
Sternini, De Giorgio, & Greenwood-Van Meerveld, 2016). EECs also express receptors implicated 
in mechanotransduction and nociceptive signaling, such as Piezo2 and transient receptor potential 
ankyrin 1 (TRPA1) (Doihara et al., 2009; Murthy et al., 2018; Nozawa et al., 2009; Szczot et al., 
2018; F. Wang et al., 2017). These epithelial cells are electrically excitable and can form synaptic 
structures with neurons (Bellono et al., 2017; Bohorquez et al., 2015). Using EEC-specific 
fluorescent reporter lines and transcriptional profiling, axon-like basal processes (a.k.a. neuropods) 
and presynaptic vesicle proteins were identified (Bohorquez & Liddle, 2011). Other studies 
targeted rabies virus to EECs in the colon and demonstrated synaptic connectivity between EECs 
(specifically, PYY-expressing cells) and surrounding neurons (Bohorquez et al., 2015), which 
include extrinsic primary afferents with cell bodies in lumbar DRG (Kaelberer et al., 2018). This 
EEC-colon ExPAN connection provides at least one potential cellular substrate for visceral pain 
transmission. 
1.2.3  Transmitters Involved in Epithelial-Neuronal Communication 
Diverse cell types within the colon express numerous signaling molecules and receptors 
that are likely to facilitate epithelial-neuronal communication. Some of these are highlighted in 
Figure 1.  
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Figure 1. The mechanisms of communication between colon epithelial cells and colon extrinsic primary 
afferent neurons (ExPANs).  
This graphic summarizes some of the key mechanisms of epithelial-ExPAN communication. Neuroactive substances 
released by specific epithelial cell types are illustrated, along with the corresponding receptors that are found on 
ExPAN terminals. In some cells, mechanisms of release are also illustrated, including the ion channels and vesicular 
transporters involved. 1) ATP: Both enterocytes and EECs release ATP (along with other cell types) and VNUT 
expression is ubiquitous in the epithelium. ATP is also co-released with hormones from L-cells. 2) Glu: VGLUT2 is 
expressed in I-cells and L-cells, and glutamate is co-released with hormones from L-cells. 3) ACh: VAChT is 
specifically expressed in tuft cells. 4) 5-HT: EC cells are a primary source of 5-HT and express the sensory receptors 
TRPA1 and Piezo2. Evidence shows that 5-HT may be released upon activation of these receptors. 5) cGMP: 
Activation of the GC-C receptor on enterocytes causes release of cGMP. 6) Trypsin-3: Epithelial cells express trypsin-
3 and release it in the presence of inflammation. Reprinted from Najjar et al. (2020), with permission. 
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1.2.3.1 Adenosine Triphosphate (ATP) 
 
One mechanism of colon mechanosensory transduction was proposed by Geoffrey 
Burnstock, a pioneer of the purinergic signaling field, who posited that colon distension leads to 
ATP release from epithelial cells, which then acts on purinergic receptors expressed on primary 
afferents (Burnstock, 2001). This hypothesis was supported by studies showing that mechanical 
stimulation of the mucosa resulted in ATP release and that ExPAN responses to mechanical 
stimulation were attenuated in the presence of purinergic receptor antagonists (Wynn, Rong, 
Xiang, & Burnstock, 2003). Distension-evoked release of ATP may be mediated, at least in part, 
by activation of transient receptor potential channel V4 (TRPV4), which is present in human and 
mouse epithelial cells (Cenac et al., 2008; D'Aldebert et al., 2011; Mihara, Uchida, Koizumi, & 
Moriyama, 2018). TRPV3 channel activation is also linked to ATP release; one study showed that 
addition of the TRPV3 agonist carvacrol to cultured colon epithelial cells increased ATP in culture 
supernatants (Ueda, Yamada, Ugawa, Ishida, & Shimada, 2009).  
The mechanisms that underlie ATP release from epithelial cells are only partially known. 
As shown for neurons and adrenal chromaffin cells (Burnstock, 1999; Zhang et al., 2019), ATP 
may be released in combination with other neurotransmitters from enterochromaffin (EC) cells or 
other EECs (Winkler & Westhead, 1980). ATP can also be co-released with hormones from EECs, 
e.g., L-cells release ATP along with GLP-1 and PYY (Lu et al., 2019). ATP is also likely released 
on its own from diverse epithelial cell types. Ubiquitous expression of vesicular nucleotide 
transporter (VNUT) in the mouse colon epithelium and in human intestinal epithelium cell lines 
suggest all epithelial types are capable of ATP release. In addition, VNUT-mediated exocytosis of 
ATP-containing vesicles may be dependent on TRPV4 activation (Mihara et al., 2018). Other 
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mechanisms of ATP release from colon epithelial cells, including ATP-permeable channels (e.g., 
pannexins), have not been ruled out (Schwiebert & Zsembery, 2003).  
Targets of ATP release on colon ExPAN endings include ionotropic P2X3 and P2X2/3 
receptors (Shinoda, Feng, & Gebhart, 2009; Wynn et al., 2003) as well as metabotropic P2Y1 and 
P2Y2 receptors (J. R. Hockley et al., 2016) expressed by muscular and vascular ExPANs (J. R. 
Hockley et al., 2016; Shinoda et al., 2009). Findings in the following chapters support these targets, 
as epithelial-neuronal signaling was blocked using a cocktail of P2X3, P2X2/3, and P2Y2 
antagonists (Makadia et al., 2018). Additionally, ATP released during distension has been shown 
to activate and sensitize TRPV1 channels on ExPANs (Lakshmi & Joshi, 2005).  
Models of visceral hypersensitivity suggest inflammation-induced changes occur in 
purinergic signaling. In the trinitro benzene sulfonic acid (TNBS) model of IBD, increased 
distension-evoked ATP release augmented ExPANs firing in response to ATP application and this 
was correlated with upregulation of P2X3 receptors in lumbosacral dorsal root ganglia (Wynn, Ma, 
Ruan, & Burnstock, 2004). ATP signaling is also implicated in colon hypersensitivity resulting 
from intracolonic infusion of zymosan (a model of post-infectious IBS), based in part on the 
absence of hypersensitivity in P2X3-/- mice (Shinoda et al., 2009). In addition, P2X3 protein level 
is higher in colon biopsies from IBD subjects (which is often accompanied by persistent pain) 
compared with control tissue (Yiangou et al., 2001). The authors hypothesized that both 
submucosal enteric neurons and primary afferent nerve endings contributed to the increase in ATP. 
Together, these studies suggest that inflammation-induced changes in ATP release (possibly from 
epithelial cells) and ATP receptor activity (on colon ExPANs) contribute to hypersensitivity.  
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1.2.3.2 Serotonin (5-hydroxytryptophan) 
 
Serotonin (5-HT) in the gut regulates peristalsis, secretion, and nociceptive signaling. 
Enterochromaffin (EC) cells make up less than 1% of the epithelium, yet they synthesize and 
release over 95% of the body’s 5-HT (Gershon, 2013). The 5-HT release machinery, located at the 
basal surface of EC cells, is in close apposition to nerve fibers (Bellono et al., 2017; Mawe & 
Hoffman, 2013). Secretory granules at the apical surface may facilitate release of 5-HT into the 
gut lumen (Fujimiya, Okumiya, & Kuwahara, 1997). EC cells are the major source of 5-HT 
whereas virtually all epithelial cells in the gut express the serotonin-selective reuptake transporter 
(SERT) and thus take part in controlling 5-HT levels (Wade et al., 1996).  
The excitatory ionotropic 5-HT3 receptor (5-HT3R) is widely expressed on colon ExPANs 
(J. R. F. Hockley, Taylor, et al., 2018) and has been implicated in visceral pain signaling. In the 
mouse model of dextran sulfate sodium (DSS)-induced colitis, an increase in 5-HT3R-positive 
nerve fibers in the colon mucosa was measured (Matsumoto et al., 2012). In vivo studies of colon 
sensitivity, measured by responses to colorectal distension (CRD), have shown that i.v. 
administration of alosetron, a 5-HT3R antagonist, diminishes these responses. Alosetron 
administration also decreased c-Fos positive neurons in the spinal cord dorsal horn in response to 
CRD (Kozlowski, Green, Grundy, Boissonade, & Bountra, 2000). Importantly, alosetron has been 
used to treat IBS-D (diarrhea-predominant) and randomized controlled trials showed pain relief. 
However, due to side effects of constipation and colitis, alosetron was withdrawn from the market 
(Fayyaz & Lackner, 2008).  
A study examining both intestinal cryosections and organoids derived from small intestine 
tissue showed that EC cells form synapse-like contacts with 5-HT3R-expressing nerve endings 
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(Bellono et al., 2017). In the same study, functional connectivity between EC cells and nerve fibers 
was revealed using a colon-nerve ex vivo preparation in which selective pharmacological 
activation of EC cells caused action potential firing in 5-HT3 positive colon mucosal ExPANs, 
presumably via the release of 5-HT (Bellono et al., 2017). Communication between nerves and EC 
cells could be initiated via EC expressed molecules that transduce sensory stimuli. For example, 
studies show that some EC cells express the mechanosensitive Piezo2 receptor, localized adjacent 
to 5-HT vesicles (Alcaino et al., 2018; F. Wang et al., 2017). Stretching of the colon tissue can 
activate Piezo2, providing a link between sensations associated with colon distension and 5-HT 
signaling. However, it should be noted that colon mechanotransduction is likely to be a shared 
responsibility of EC cells and ExPANs; ExPANs also express Piezo2, most frequently in 
neurofilament-positive populations (J. R. F. Hockley, Taylor, et al., 2018). TRPA1 is another 
potential stimulus-transducing molecule expressed by EC cells. In the context of gustatory 
perception, this ligand-gated receptor is responsible for the oral cavity’s ability to detect molecules 
like allyl isothiocyanate (found in mustard oil, wasabi, and horseradish) and cinnamaldehyde 
(found in cinnamon). The presence of TRPA1 in colon EC cells supports the concept that these 
cells can act as “taste buds” of the colon (Bertrand, 2009) and as sensors of chemical irritants. Like 
Piezo2, TRPA1 is expressed in colon ExPANs and its deletion degrades, but does not eliminates 
mechanosensory function (Brierley et al., 2009), indicating mechanistic redundancy for this 
sensory modality that could include a role for the epithelium.  
Several studies have examined the role of 5-HT in visceral pain disorders. One study 
reported that inflamed colon tissue samples from IBD patients have decreased 5-HT compared to 
controls, decreased SERT levels and fewer 5-HT-immunoreactive EC cells per crypt in the mucosa 
(Coates et al., 2004). In contrast, animal models of colitis (TNBS and DSS) display increases in 
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EC cell count and mucosal 5-HT content (Bertrand, Barajas-Espinosa, Neshat, Bertrand, & Lomax, 
2010; Linden et al., 2005). The discrepancy in EC cell count and 5-HT levels could be due to 
limitations of the models, where acute colitis does not directly compare to the chronic 
inflammation in human IBD (Mawe & Hoffman, 2013).  
Studies of 5-HT signaling in IBS have also shown conflicting results. One study compared 
patients with IBS-D (diarrhea-predominant) and IBS-C (constipation-predominant). Both groups 
had decreased mucosal SERT expression and no change in EC density or in tissue agitation-evoked 
5-HT release (Coates et al., 2004). Another study showed that colon samples from post-infectious 
(PI) IBS patients had significantly more 5-HT-immunoreactive EC cells per imaging field 
compared to healthy controls, whereas non-PI-IBS samples showed no difference in EC cell count 
(Lee et al., 2008). In an analysis of samples from IBS patients of all phenotypes, no difference in 
EC cell count or 5-HT content was found between patients with and without hypersensitivity 
(Kerckhoffs, ter Linde, Akkermans, & Samsom, 2012). Thus, 5-HT signaling may be altered in 
IBS, but its role in colon hypersensitivity and pain remain unclear. 
1.2.3.3 Glutamate 
 
Glutamate is another epithelial-derived transmitter involved in sensory signaling. PYY- 
and CCK-expressing EECs have been shown to release glutamate (Kaelberer et al., 2018) and the 
vesicular glutamate transporter 2 (VGLUT2) colocalizes with PYY and GLP-1 throughout the 
intestines (Hayashi, Morimoto, Yamamoto, & Moriyama, 2003). Additional culture studies using 
a neuroendocrine cell line (GLUTag) showed that glutamate is co-released with GLP-1 in response 
to KCl or glucose (Uehara et al., 2006). 
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Glutamate receptors are expressed by colon ExPANs and are implicated in visceral 
hypersensitivity (Blackshaw, Page, & Young, 2011). Single cell RNA sequencing indicates several 
types of glutamate receptors are expressed across subtypes of ExPANs, including the ionotropic 
AMPA and NMDA receptors, and the metabotropic receptors mGluR1-5 (J. R. F. Hockley, Taylor, 
et al., 2018). Studies in rat showed mGluR5 antagonists diminish visceromotor responses to CRD 
and, in an ex vivo colon-nerve preparation, decrease muscular and serosal colon ExPAN responses 
to mechanical stimulation (Lindstrom et al., 2008). Changes in NMDA receptors (NMDAR) are 
also associated with IBS. Specifically, IBS patients were shown to have upregulation of NMDAR, 
which correlated with abdominal pain scores, whereas mice showed increased sensitivity to 
colorectal distension in response to intracolonic administration of NMDA (Q. Qi et al., 2017). 
These findings complemented previous reports showing that NMDAR antagonists prevented 
hypersensitivity in a mouse model of TNBS-induced colitis (Q. Q. Qi et al., 2016).  
A recent study employed rabies virus retrograde tracing in mice to show that PYY- and 
CCK-positive EECs synapse with DRG afferent fibers (Kaelberer et al., 2018). Many EECs were 
shown to co-express VGLUT2 and CCK. Optogenetic activation in vitro confirmed that CCK-
positive EECs release glutamate, causing activation of vagal neurons. These studies support the 
idea that EECs use glutamate to signal to ExPANs. 
1.2.3.4 Acetylcholine (ACh) 
 
The ACh synthesizing enzyme choline acetyltransferase (ChAT) is one of the commonly 
used indicators of ACh production. Expression of ChAT in the intestinal epithelium has been 
recognized for decades (Porter, Wattchow, Brookes, Schemann, & Costa, 1996). ACh may be an 
important transmitter between tuft cells, which express ChAT, and surrounding neurons (Gautron 
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et al., 2013). The vesicular acetylcholine transporter (VAChT), another indicator of ACh 
production, has been detected via immunohistochemistry in both human (Jonsson, Norrgard, & 
Forsgren, 2007) and mouse (Schutz et al., 2015) intestinal epithelium. In mice, VAChT is 
expressed in only about 20% of ChAT-expressing tuft cells in the proximal colon and not detected 
in distal colon or small intestine (Schutz et al., 2015). In VAChT+ tuft cells, ACh may be released 
through synaptic vesicles, but in VAChT- cells, ACh may be released via organic cation 
transporters (Wessler et al., 2001), or gap junctions (Huang & Roper, 2010).  
Nicotinic ACh receptors (nAChR) are expressed on colon ExPANs, but their role in 
visceral pain is unclear. Single cell RNAseq analysis has shown high levels of nAChRα subunits 
3-7 in colon ExPANs (J. R. F. Hockley, Taylor, et al., 2018). Another study showed nAChRα3 
expression in about 50% of peptidergic afferents that innervate visceral organs. This study also 
showed that in skin, mechanically insensitive afferents (MIAs), also known as “silent” nociceptors, 
can be defined by expression of nAChRα3 (Prato et al., 2017), raising the possibility that MIAs 
that innervate the colon also express nAChRα3.  
Although tuft cells represent only 0.4% of intestinal epithelial cells (in the mouse), they 
have an important role in mediating immune responses (Gerbe & Jay, 2016). They are a primary 
source of interleukin-25, which recruits helper T cells and innate lymphoid cells during infection 
(Fallon et al., 2006). They also express cyclooxygenase enzymes (COX1 and COX2), which 
produce inflammatory prostaglandins (Bezencon et al., 2008). Recent evidence suggests tuft cells 
also initiate a type 2 immune circuit in response to succinate, a metabolite secreted by parasitic 
helminths (Nadjsombati et al., 2018). Visceral hypersensitivity, which often occurs with infection, 
is thought to result from an inflammatory response to the parasite. As suggested by this study, this 
response may be initiated by succinate activation of tuft cells and subsequent activation of sensory 
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signaling pathways. The role of tuft cells in prolonged inflammatory conditions such as IBD is 
unclear, but alteration in the gut’s non-neuronal cholinergic system is a possible link. Evidence 
consistent with this idea comes from immunohistochemical and mRNA analyses of human colon 
tissue, which show that patients with ulcerative colitis expressed significantly lower levels of 
ChAT and VAChT in the colon epithelium (Jonsson et al., 2007). 
1.2.3.5 Proteases 
 
Proteases released by colon epithelial cells are likely regulators of colon ExPANs 
hypersensitivity. Supernatants obtained from IBS colon biopsies increase the excitability of 
sensory neurons in culture, an effect that is blocked by protease inhibitors (Valdez-Morales et al., 
2013). These supernatants also induce visceral hypersensitivity in mice, but not in the presence of 
a protease-activated receptor-2 (PAR2) antagonist or in PAR2-deficient mice (Cenac et al., 2007). 
In addition, application of a PAR2 agonist (SLIGRL-NH2) into the colon lumen results in 
hypersensitivity to colorectal distension and increased Fos expression in the spinal cord dorsal 
horn (Coelho, Vergnolle, Guiard, Fioramonti, & Bueno, 2002). Electrophysiology studies have 
shown PAR2 sensitizes serosal ExPANs via a TRPV4-dependent mechanism (Sipe et al., 2008). 
Colon epithelial cells, enterocytes in particular, are a source of proteases; addition of 
lipopolysaccharide (LPS) to Caco-2 cells in culture caused release of the protease trypsin-3 
(Rolland-Fourcade et al., 2017). Trypsin-3 has been shown to induce colorectal hypersensitivity 
in a PAR2-dependent manner and is increased in epithelium of colon biopsies of human IBS 
patients and rat IBS models (Rolland-Fourcade et al., 2017).  
Efforts to identify proteases active in IBS and IBD patients are ongoing. Functional 
proteomic assays of colon tissue and supernatants from IBD patients (both ulcerative colitis and 
 16 
Crohn’s disease), showed increased trypsin-like activity as well as overactive cathepsin G and 
thrombin activity in IBD patients (Denadai-Souza et al., 2018). How human colon ExPANs 
respond to proteases is also unclear; although PAR2 is expressed in 40% of human sensory afferent 
neurons, neuronal responses to supernatants from IBS patients are mediated by PAR1 (Desormeaux 
et al., 2018).  
1.2.3.6 Cyclic guanosine-3’,5’-monophosphate (cGMP) 
 
Signaling molecules released from colon epithelial cells may also inhibit neural activity. 
One such molecule is cGMP, which is released upon activation of the epithelial guanylate cyclase 
C (GC-C) receptor (Huott, Liu, McRoberts, Giannella, & Dharmsathaphorn, 1988). Linaclotide, a 
drug prescribed for IBS-C for relief of pain and constipation, is a peptide agonist of GC-C, a 
transmembrane receptor expressed on the luminal aspect of the intestinal epithelium that also binds 
bacterial enterotoxins (responsible for traveler’s diarrhea) and peptide hormones (e.g., guanylin) 
(Hannig et al., 2014). In randomized controlled trials, linaclotide reduced abdominal pain in over 
60% of patients (Castro et al., 2013). Linaclotide’s binding to GC-C stimulates the synthesis and 
release of cGMP from epithelial cells, which has effects that are twofold: stimulation of fluid 
production in the intestinal lumen and inhibition of colon ExPAN activity (Busby et al., 2010). 
The increase in epithelial cGMP initiates a protein kinase-dependent pathway which activates the 
cystic fibrosis transmembrane regulator (CFTR), increasing secretion of bicarbonate and chloride 
into the lumen. These secretions inhibit the sodium/hydrogen exchanger, leading to fluid secretion 
into the lumen (Lacy, Levenick, & Crowell, 2012). The increased production of cGMP in the 
epithelial cells leads to more extracellular cGMP, which has been shown to inhibit colon ExPAN 
firing via a membrane receptor target, though little is known about the identity of this target 
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(Grundy et al., 2018). Linaclotide itself does not reduce ExPAN excitability; only cGMP released 
from the epithelium has this effect.  
In rodent ex vivo preparations, cGMP applied to the colon lumen decreased colon ExPAN 
firing rates (Castro et al., 2013; Feng et al., 2013). This effect was more robust in a mouse model 
of TNBS-induced colon inflammation (Grundy et al., 2018). Patch clamp analysis of cultured 
human DRG neurons also showed greater effectiveness of cGMP in the presence of inflammatory 
mediators (Grundy et al., 2018). Although the mechanisms involved in cGMP-induced inhibition 
remain unclear, further investigation of cGMP targets is warranted as this approach has significant 
therapeutic potential. 
1.2.4  Summary of Epithelial-Sensory Afferent Communication 
Colon epithelial cells, EECs in particular, are likely to have a significant influence on the 
activity of colon ExPANs and visceral pain signaling. This idea is explored in Chapter 2, which 
describes studies in which colon ExPAN activity and nociceptive responses are measured in 
response to colon epithelium activation. Chapter 3 also proposes a role for the colon epithelium in 
pain signaling, demonstrating the effects of colon epithelium inhibition on nociceptive responses. 
The neuroactivators released by epithelial cells that are most likely to be involved in this 
epithelial-neuronal communication are summarized in Table 1. This table shows each 
neurotransmitter and its epithelial cell sources, as well as the model systems and techniques that 
have been used to identify the sources of each transmitter.  
As summarized in Figure 1, colon epithelial cells express some of the same sensory 
receptors that are found in colon ExPANs, indicating that they have a role in monitoring the 
environment in the gut lumen. This is supported by studies showing that colon ExPAN responses 
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to mechanical stimuli are diminished when epithelium-released neurotransmitters are blocked 
(Makadia et al., 2018; Wynn et al., 2003). In many cases, transmission from epithelial cells may 
be diffuse and have slow or indirect actions on colon ExPANs terminals. However, communication 
from some EECs to colon ExPANs may be achieved through direct synaptic transmission. 
Enterochromaffin cells (ECs) are one type of EEC that show evidence of these synapses and they 
contain the receptors TRPA1 and Piezo2, which are critical in mechanosensation and pain 
signaling (Alcaino et al., 2018; Bellono et al., 2017). This receptor expression profile and 
connectivity with surrounding colon ExPANs may indicate that ECs have a more salient role in 
sensory signaling than other cell types.  
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Table 1. Major regulators of epithelial-neuronal communication in the small intestine and colon. 
Transmitter Epithelial 
Cell Source 
Model System Techniques Used to Identify 
Source of Transmitter 
Ref 
Acetylcholine 
(ACh) 
Tuft cells Mouse: small 
intestine and 
colon tissue 
Immunohisto-chemistry 
(IHC), in situ 
hybridization, transgenic 
fluorescent reporter 
(Porter et 
al., 1996) 
Adenosine 
triphosphate 
(ATP) 
All Rat: colon tissue Luciferin-luciferase, ATP 
release assay 
(Wynn et 
al., 2003) 
 All Human: CCD 
841 cell line 
Luciferin-luciferase, ATP 
release assay 
(Mihara et 
al., 2018) 
 All Mouse: colon 
epithelium 
primary culture 
Luciferin-luciferase, ATP 
release assay 
(Ueda et 
al., 2009) 
 L-cells GLUTag cell 
line  
 
 
 
Mouse: cultures 
of small intestine 
epithelium  
Human: culture 
of colon 
epithelium  
Epithelial-neuronal co-
cultures, luciferin-
luciferase ATP release 
assay, sniffer patch 
 
IHC 
 
 
 
 
IHC 
(Lu et al., 
2019) 
 All CCD 841 cell 
line 
 
Mouse: colon 
tissue 
qRT-PCR, IHC, luciferin-
luciferase assay 
 
qRT-PCR, IHC 
(Mihara et 
al., 2018) 
Glutamate (Glu) L-cells Rat: small 
intestine tissue 
IHC (Hayashi 
et al., 
2003) 
 L-cells GLUTag cell 
line 
In vitro chemically evoked 
release 
(Uehara et 
al., 2006) 
 I-cells Mouse: small 
intestine tissue 
IHC, in vitro optogenetics (Kaelberer 
et al., 
2018) 
Cyclic 
guanosine-3’,5’-
monophosphate 
(cGMP) 
All Human: T84 cell 
line 
Enzyme immunoassay (Busby et 
al., 2010) 
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Table 1 Continued 
Serotonin (5-HT) EC cells Rat: small 
intestine tissue 
Immunoelectron 
microscopy 
(Fujimiya 
et al., 
1997) 
 EC cells Mouse: small 
intestine, 
cultured 
organoids, ex 
vivo colon-nerve 
preparation 
IHC, in vitro 
electrophysiology, 5-HT 
biosensors (sniffer patch) 
(Bellono 
et al., 
2017) 
 EC cells Mouse: small 
intestine and 
colon, cultured 
organoids 
IHC, in vitro calcium 
imaging, 5-HT biosensors 
(sniffer patch) 
(Alcaino 
et al., 
2018) 
Trypsin-3 All Rat: colon tissue 
 
Human: colon 
tissue, Caco-2 
cell line 
IHC, Western blot 
 
IHC, Western blot 
(Rolland-
Fourcade 
et al., 
2017) 
 
1.3 Communication Between the Colon Epithelium and Enteric Nervous System 
1.3.1  Intrinsic Innervation of the Colon 
The colon contains intrinsic neurons as part of the enteric nervous system (ENS), which 
are essential for peristalsis, mucous and acid secretion, and nutrient absorption (Furness, 2012). 
The ENS has been referred to as the “brain-in-the-gut” or the “second brain” because of its 
expansive network of neurons (numbering over 500 million) which carry out complex sensory and 
motor functions (Gershon, 1999; Wood, 2016). Enteric neurons control motility in the small 
intestine and colon through coordination of smooth muscle contractions that propel food and fecal 
contents along the gut. Interconnected enteric neurons and glia form two plexuses within the colon 
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wall: the myenteric plexus resides between the longitudinal and circular muscle layers and the 
submucosal plexus between the circular muscle layer and mucosal layer (Costa, Brookes, & 
Hennig, 2000).  
Proper gut motility relies on ENS reflexes, which are initiated by sensory neurons that are 
unique to the GI tract, called intrinsic primary afferent neurons (IPANs). IPANs sense chemical 
and mechanical (e.g., stretch) stimuli in the lumen and send this sensory information to other 
enteric neurons to facilitate digestion (Furness, 2012). These neurons include excitatory and 
inhibitory motor neurons, and ascending and descending interneurons, which coordinate functions 
such as secretion, vasodilation, and smooth muscle contraction (Furness, 2000). Propulsion of food 
and fecal contents requires coordinated motor patterns in different segments along the gut 
involving both contraction and relaxation of smooth muscle, hence the diversity of excitatory and 
inhibitory cell types in the ENS (Figure 2). Most of the ENS neurons associated with motor 
function are located in the myenteric plexus and IPANs originating in these ganglia have processes 
that extend into the mucosa, enabling detection of luminal contents (Furness, Robbins, Xiao, 
Stebbing, & Nurgali, 2004). Considering how important gut motility is to overall health, it is 
critical to understand this sensory component of ENS reflexes. 
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Figure 2. Colon enteric nervous system reflexes and the role of the epithelium. 
Intrinsic primary afferent neurons (IPANs) in the myenteric plexus project to the mucosa to detect luminal contents. 
In response to chemical and mechanical stimuli, IPANs signal to interneurons (INs) and motor neurons (MNs) to 
produce propulsive smooth muscle contractions. In this example, a myenteric IPAN signals to ascending INs which 
synapse with excitatory MNs to produce contraction in the oral direction. The IPAN also signals to descending INs 
which synapse with inhibitory MNs to produce relaxation in the anal direction. Epithelial cells in the mucosal layer 
also sense luminal contents and release neurotransmitters in response (inset). In this example, enterocytes and an 
enterochromaffin cell release ATP and 5-HT, respectively, which can act on local IPAN terminals to initiate reflexes. 
Image created in BioRender. 
1.3.2   Role of the Colon Epithelium in ENS Functions 
Reciprocal interactions between the epithelium and ENS neurons are thought to have an 
important role in colon homeostasis. This epithelial-neuronal communication is thought to be 
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paracrine, where molecules diffuse from one cell and act on nearby receptors (Walsh & Zemper, 
2019). Although studies show synaptic connections between EEC neuropods and extrinsic neurons 
in the gut (Kaelberer et al., 2018), it has not yet been determined whether neuropods form synapses 
with intrinsic ENS neurons. Studies performed in intestinal organoids show that the ENS 
influences proliferation and differentiation of cell types in the epithelium (Workman et al., 2017). 
ENS neurons also influence the function of epithelial cells; namely, cholinergic ENS neurons 
innervating the epithelium trigger mucous secretion (Specian & Neutra, 1980).  
 Conversely, colon epithelial cells are influential in ENS function, particularly in sensory 
signaling. In the mucosa, IPAN nerve endings lie in close apposition to epithelial cells. Evidence 
shows that IPANs can sufficiently detect mechanical stimuli in the lumen to initiate enteric reflexes 
(Bertrand, Kunze, Bornstein, & Furness, 1998), but it has been proposed that the epithelium acts 
as an intermediary between luminal stimuli and ENS neurons. ATP and 5-HT are the two major 
epithelial-released neurotransmitters thought to have excitatory actions on ENS neurons (Bertrand, 
2003) (Figure 2). Enterochromaffin (EC) cells are thought to be the main epithelial cell type 
involved, as they are the body’s main source of 5-HT, an important signaling molecule in the ENS. 
As previously discussed, EC cells express receptors for chemical irritants (TRPA1) (Nozawa et 
al., 2009), and mechanical stimulation (Piezo 2) (Alcaino et al., 2018). EC cells release 5-HT in 
response to activation of these receptors, which is thought to act on local ENS neurons and initiate 
colon motility (Grider, Kuemmerle, & Jin, 1996; Kadowaki, Wade, & Gershon, 1996; Nozawa et 
al., 2009).  
Despite the evidence of the epithelium’s role in sensory signaling, the extent to which 
endogenous neurotransmitter release from colon epithelial cells activates IPAN nerve terminals is 
a major unanswered question. Additionally, it has been debated whether the epithelium has an 
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essential role in colon motility, particularly in colonic migrating motor complexes (CMMCs), 
which are rhythmic motor patterns that facilitate the movement of fecal matter through the colon 
(Spencer, 2001). Some researchers report that mucosal 5-HT is essential for normal propagation 
of motor patterns in the colon (Heredia, Dickson, Bayguinov, Hennig, & Smith, 2009; Heredia et 
al., 2013; Smith & Gershon, 2015), while others report that motor patterns are generated in the 
myenteric plexus and/or smooth muscle layers and do not require signaling from the mucosa, 
though mucosal serotonin may have a modulatory role (Keating & Spencer, 2010; Spencer, Sia, 
Brookes, Costa, & Keating, 2015). Given these discrepancies, more specific tools are needed to 
discern how epithelial activation affects ENS activity and whether the epithelium has a direct or 
modulatory role. The experimental techniques described in Chapter 4 provide a means to address 
these questions. 
1.4 Optogenetic Tools for Activating Neuronal and Non-Neuronal Cells  
Optogenetics refers to the expression of light-activated proteins, called opsins, in specific 
cell populations to enable manipulation of activity in those cells. The first successful expression 
of the algae-derived protein Channelrhodopsin-2 (ChR2) in mammalian neurons was demonstrated 
in 2005 (Boyden, Zhang, Bamberg, Nagel, & Deisseroth, 2005) and, since then, many types of 
excitatory and inhibitory opsins have been engineered. ChR2 is a blue light-activated non-selective 
cation channel that, when genetically expressed in the cell membrane, enables depolarization of 
the cell (Nagel et al., 2003) (Figure 3). This opsin is still commonly used to excite specific cell 
types with temporal precision. Conversely, inhibitory opsins are used to silence the activity of 
specific cell types. For example, the yellow light-activated archaerhodopsin (Arch) is an outward 
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proton pump that can mediate hyperpolarization of neurons upon activation (Chow et al., 2010) 
(Figure 3). Among many other purposes, optogenetic tools have been useful in interrogating 
peripheral pain circuits and ENS function. 
 
Figure 3. Excitatory and inhibitory opsins. 
Opsins used in the following studies include the excitatory channelrhodopsin-2 (ChR2), a non-selective cation channel 
activated by ~470 nm light and the inhibitory archaerhodopsin (Arch), an outward proton pump activated by ~590 nm 
light. These opsins can be transgenically expressed in specific cell types using Cre/Lox recombination technology. 
 
Opsins can be genetically targeted using viral techniques or transgenic methods using 
Cre/Lox recombination technology. Both have been used to investigate specific populations of 
sensory neurons (Mickle & Gereau, 2018). Studies in mice have demonstrated that stimulating 
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ChR2 targeted to neurons expressing TRPV1 (Baumbauer et al., 2015), Nav1.8 (Daou et al., 2013), 
or Advillin (Park et al., 2015) can evoke nociceptive-live behaviors. On the other hand, expression 
of Arch in these neuron populations enables an analgesic effect. For example, silencing of Nav1.8-
expressing peripheral neurons attenuated inflammatory pain (Daou et al., 2016). Many of these 
studies were performed by shining blue light on the skin or along the nerve.  
Peripheral optogenetic manipulation of visceral organs is also possible, for example 
Advillin-ChR2 has been used to interrogate extrinsic primary afferents innervating the colon 
(Feng, Joyce, & Gebhart, 2016). In a study of bladder afferents, ChR2 was targeted to both 
TRPV1- and Nav1.8-expressing neurons to reveal the role of each subpopulation on bladder 
nociception and voiding function (DeBerry et al., 2018). Activation of Arch expressed in bladder 
afferents attenuated nociceptive responses in a visceral inflammatory pain model (Samineni et al., 
2017). More recently, these tools have been employed in gut motility studies, where 
subpopulations of ENS neurons are targeted with ChR2 to reveal their contributions to neurogenic 
motor patterns (Hibberd, Feng, et al., 2018).  
Excitatory and inhibitory opsins can also be expressed in non-neuronal cells. While there 
is evidence of intercellular communication between neurons and epithelial cells, endothelial cells, 
and glia, this intercellular signaling has been difficult to study because of their close association 
with neurons. Optogenetic tools enable activation of these cell types without influencing the 
surrounding neurons and enable measurement of their impact on neural activity and behavioral 
outputs (Mickle & Gereau, 2018). Studies have shown that ChR2-mediated activation of Merkel 
cells and keratinocytes result in sensory afferent action potential firing and nociceptive responses 
(Baumbauer et al., 2015; Maksimovic et al., 2014). Optogenetic inhibition of keratinocytes 
inhibited sensory responses to mechanical stimulation (Baumbauer et al., 2015; Moehring et al., 
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2018). More recently, a study showed that the Schwann cells that ensheathe peripheral nerve 
endings also contribute to sensations from the skin (Abdo et al., 2019).  
In studies of this dissertation, ChR2 and Arch were employed to modulate both colon 
ExPANs and colon epithelial cells. In Chapter 2, ChR2 was used to investigate the role of the colon 
epithelium in sensory signaling and responses were compared to direct ChR2-mediated activation 
of colon ExPANs. In Chapter 3, Arch was targeted to the colon epithelium and ExPANs to 
investigate the role of the colon epithelium in visceral hypersensitivity associated with 
inflammation. Finally, in Chapter 4, ChR2 was targeted to the colon epithelium to examine its 
effects on ENS neuron activity and gut motility.  
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2.0 Optogenetic Activation of Colon Epithelium Produces High-Frequency Bursting in 
Extrinsic Colon Afferents and Engages Visceromotor Responses 
2.1 Introduction 
The epithelial-lined mucosa of the colon is innervated by autonomic and sensory nerve 
fibers of intrinsic and extrinsic origin (Spencer, Kyloh, & Duffield, 2014). Understanding how 
activation of these nerve fibers is regulated at this important interface is of significant clinical and 
biological interest, particularly for understanding their role in pain signaling in chronic 
inflammatory conditions of the gut. In recent studies of the epithelium covering the skin it has been 
possible to demonstrate that excitation of epithelial cells alone can directly produce action 
potentials in primary sensory neurons in the absence of naturalistic mechanical, thermal, or 
chemical stimulation (Baumbauer et al., 2015; Maksimovic et al., 2014; Pang et al., 2015). 
Epithelial cells, genetically modified to express channelrhodopsin (ChR2) and stimulated with 
blue light, were shown to elicit firing in diverse types of cutaneous sensory neurons, including 
those that sense pain and mechanical stimuli (Baumbauer et al., 2015). The colon epithelium, 
comprised of absorptive enterocytes, endocrine cells, and goblet cells has features in common to 
the skin epithelium; it interfaces with the internal environment of the gut and is the first line of 
defense for the colon, protecting it from a wide range of pathogenic and chemical insults within 
the colon lumen. Similar to keratinocytes of the skin, colon epithelial cells can release several 
types of neuro-activator compounds, including classic neurotransmitters such as acetylcholine 
(ACh), ATP, and 5-hydroxytrypamine (5-HT/serotonin), and peptides and hormone transmitters, 
such as somatostatin and peptide YY (Bertrand, 2009; Gunawardene et al., 2011; Rindi, Leiter, 
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Kopin, Bordi, & Solcia, 2004). Released neuromodulators are thought to both stimulate and inhibit 
neurons of the myenteric plexus, as well as act on primary sensory afferents from the dorsal root 
ganglia (DRG), through activation of metabotropic and ionotropic receptor proteins, e.g., 
muscarinic or nicotinic acetylcholine receptors, purinergic receptors, and/or serotonergic receptors 
(Bertrand, 2003; Bornstein, 2006; Burnstock, 2014; King, 2015; Linan-Rico et al., 2015; Linden, 
Chen, Gershon, Sharkey, & Mawe, 2003; Mawe, 2015; Wynn et al., 2004). Few studies have 
examined how compounds, potentially derived from the colon epithelium, can initiate neuronal 
action potentials in the absence of other naturalistic stimuli (Bellono et al., 2017; J. R. F. Hockley, 
Taylor, et al., 2018; Wynn et al., 2004). Given the inconclusive evidence for direct activation of 
nerve fibers by colon epithelial cells and the recent finding that skin epithelial cells can 
independently initiate action potentials in DRG sensory fibers, we examined the contribution of 
the colonic epithelium to generation of action potentials in colon ExPANs. To allow epithelial-
specific activation we targeted ChR2 to colonic epithelial cells to determine whether light-induced 
activation of these cells could generate action potentials in ExPANs. Our results show that almost 
one-half of all colon ExPANs fired high-frequency trains of action potentials in response to light 
activation of the epithelium, often in patterns similar to those evoked by mechanical stimulation. 
In addition, the response of 70% of the epithelial-activated ExPANs exhibited a significant 
decrease in firing frequency when stimulated in the presence of blockers of P2X- and P2Y-
receptor-mediated neurotransmission, suggesting that ATP and/or UTP are major components of 
epithelial cell – colon ExPAN excitation coupling. Using the visceromotor response (VMR) as an 
in vivo assay, it was also determined that light stimulation of epithelial lining cells alone is 
sufficient to elicit behavioral changes similar to those obtained in response to colon distension. 
That colon epithelial cells alone have the ability to directly initiate ExPAN firing and cause 
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behavioral response supports a central role for these cells in colon function and physiology and 
indicate that the epithelium not only serves as a barrier and source of chemical modulators, but 
also provides a means for direct transmission of stimuli from the colon lumen to the nervous 
system. 
2.2 Methods 
2.2.1  Animals 
Male and female mice 6 –10 weeks of age were analyzed. Mice with a fusion protein of 
ChR2 and EYFP [ChR2(H134R)-EYFP] in the Rosa26 locus downstream of a floxed-STOP 
cassette (Ai32 mice) were crossed with either TRPV1-Cre or villin-Cre mice. Littermates with 
ChR2-EYFP but lacking Cre were used as controls. Animals were maintained in an association for 
assessment and accreditation of laboratory animal care (AAALAC) approved facility and handled 
following protocols approved by the University of Pittsburgh Institutional Animal Care and Use 
Committee. 
2.2.2  Tissue immunolabeling 
L5, L6, and S1 DRG and distal colon segments were fixed in 4% paraformaldehyde, 
cryoprotected in 25% sucrose, embedded in optimal cutting temperature (OCT) compound 
and sectioned on a cryostat at either 14 µm (for DRG) or 20 µm (for colon). Air dried sections 
were washed in phosphate buffered saline (PBS), incubated overnight at room temperature in 
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anti-PGP 9.5 (1:500; rabbit polyclonal, ThermoFisher, PA1-21097) made in PBS/0.25% Tri- 
ton X-100, washed, incubated in donkey anti-rabbit-Cy3 (1:500; Jackson ImmunoResearch), 
washed, coverslipped, and images captured using a digital camera attached to a Leica 
DM4000B microscope. 
2.2.3  Reverse-transcriptase polymerase chain reaction analysis 
The relative expression level of ChR2-YFP mRNA was determined using reverse 
transcriptase PCR analysis. Total RNA isolated from the distal colon was purified using the 
Quick-RNA miniprep kit (Zymo Research), DNase (Invitrogen), and reverse-transcribed 
using Superscript II (Invitrogen). Primers for ChR2 (5'TGG CTC TGT ACT TGT GCC TG3' 
and 5'TGA CCA TCT CGA TAG CGC AC3') and GAPDH (5'ATG TGT CCG TCG TCG 
TGG ATC TGA and 5'ATG CCT GCT TCA CCA CCT TCT T3') were used in SYBR Green 
PCR amplification reactions performed using a Bio-Rad CFX system. Relative fold-change 
was calculated using the ∆ ∆Ct method with GAPDH as standard. 
2.2.4  In vitro single-fiber recording from colon-pelvic nerve 
Mice killed with isoflurane were transcardially perfused with carbogenated (95% O2, 5% 
CO2) ice-cold artificial CSF (ACSF) containing the following (in mM: 117.9 NaCl, 4.7 KCl, 
25 NaHCO3, 1.3 NaH2 PO4, 1.2 MgSO4 -7 H2O, 2.5 CaCl2, 11.1 D-glucose) and the distal 
colorectum (~3 cm) removed with the attached major pelvic ganglion and pelvic nerve 
(PN). Tissues were transferred to ice-cold modified Krebs’ solution (Krebs’ solution containing 
2 mM butyrate, 20 mM sodium acetate, 4 µM nifedipine, and 3 µM indomethacin bubbled with 
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carbogen (Brierley et al., 2004; Feng, Brumovsky, & Gebhart, 2010) and then to an acrylic organ 
bath consisting of two adjacent chambers separated by a plastic gate with a small opening. The 
colon was opened longitudinally along the mesenteric border, placed in a Sylgard 182 (Dow 
Corning) lined chamber with circulating Krebs’ maintained at 34°C and pinned flat with mucosal 
side up. The spinal nerve containing afferents from the L6 DRG, which contributes to both the 
pelvic nerve and lumbar splanchnic nerve, was dissected and followed out to the fat pad located 
near the junction of the bladder and the colon (see Figure 5A,B). For the purpose of recording, the 
entire L6 ventral ramus that gives off branches that run into the fat pad was placed in the recording 
chamber and the fat pad and nerves contained within positioned under the Plexiglas divider that 
separates the recording chamber from the colon. To obtain nerve fascicles that contain afferent 
fibers that innervate the colon, the L6 ventral primary ramus (i.e., the PN) is placed onto a mirror 
in the recording chamber containing mineral oil. Under a dissection microscope, the nerve sheath was 
removed and the nerve trunk teased into fine bundles (~10 µM thick) that were placed onto a platinum-
iridium recording electrode for single-fiber electrophysiological recordings. 
2.2.5  Characterization of pelvic afferents  
Teased fibers of the PN were characterized using the classification system previously 
described (Brierley et al., 2004; Lynn & Blackshaw, 1999). Fibers that were activated by 
circumferential stretch were designated as “muscular”, or “muscular/mucosal” if they also 
responded to gentle stroking of the mucosa. Fibers that only responded to blunt probing were 
classified as “serosal”, whereas those that only responded to gentle mucosal stroking were 
designated as “mucosal”. Receptive fields were identified by first stroking the mucosal surface with 
a brush to locate mechanosensitive ExPANs. Responsiveness to blue-light stimulation was then 
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determined using a 473 nm wavelength laser (Laserglow Technologies) and power meter readings 
taken to estimate the average wattage reaching the tissue (40 mW at maximum power) over a 200 
µm spot size (delivered via a 100 µm fiber-optic light guide). Mechanical stimuli were then applied 
to further classify ExPANs as serosal, muscular, mucosal, or muscular/mucosal: probing with 
nylon monofilaments (von Frey filaments, 1–1.4 g force), mucosal stroking with calibrated nylon 
filaments (10 mg force) and circumferential stretch generated using a servo-controlled force 
actuator (Aurora Scientific). Custom-made claws (1 mm interval) were attached along a mesenteric 
edge of the colorectum to allow for uniform circumferential stretch by slow ramped force (0–170 
mN at 5 mN/s). The circumferential stretch generated corresponds to intraluminal pressures of 0–
45 mmHg (Feng et al., 2010). 
2.2.6  ATP antagonist pharmacology 
2.2.6.1 Villin-ChR2 responsive ExPANs 
Once receptive fields of fibers were identified with blunt probing, blue-light laser at a 
minimal intensity (1–2 mW) was placed in the field. Light stimulation was removed for 3–5 min 
to allow the fiber to equilibrate and then turned on at a maximal intensity of 40 mW for at least 10 
s (but no longer than 60 s) to determine whether each ExPAN responded to light activation of the 
epithelium. For light responsive fibers, a combination of three antagonists was then added to the 
bath: pyridoxal phosphate-6-azo(benzene-2,4-disulfonic acid) tetrasodium salt hydrate (PPADS; 
Sigma-Aldrich); P2X antagonist (and P2Y1 antagonist at higher concentrations than used here); 
2’,3’-O-(2,4,6-trinitrophenyl) adenosine 5’ triphosphate tetrasodium salt (TNP-ATP; Sigma-
Aldrich); P2X1, P2X3, P2X2/3 antagonist; and AR-C118925XX (selective P2Y2 antagonist; Tocris 
Bioscience) at final concentrations of 100, 3, and 10 mM, respectively. After 10 min of drug 
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incubation, the fiber was stimulated with blue light for 10 s. The drug cocktail was then washed 
out for 10 min or until 600 mL of fresh ACSF had flowed through the recording chamber (~20 
times the chamber volume). The field was again stimulated with blue light and response recorded. 
Response to drug mixture was defined as ≥25% reduction in average firing rate with drug 
application and recovery of firing rate by ≥25% (Brierley et al., 2005; Hicks et al., 2002).  
2.2.6.2 Stretch-responsive ExPANs 
Effects of the ATP antagonist mixture on stretch activation of TRPV1-ChR2 colon 
ExPANs used the same pharmacological protocol but without laser stimulation. Stretch-sensitive 
fibers were identified and baseline circumferential stretch obtained followed by 10 min of exposure 
to the mixture of ATP receptor antagonists. Drugs were washed out and circumferential stretch 
repeated and the response recorded. For the ATP experiments, five Vil-ChR2 mice (3 males, 2 
females) and three TRPV1-ChR2 mice (2 males, 1 females) were used.  
2.2.7  Data recording and analysis 
Action potentials generated by PN afferents were recorded using a low-noise AC 
differential amplifier (DAM80; World Precision Instruments) as described previously (Feng et al., 
2010; Feng & Gebhart, 2011). Electrical signals were filtered (0.01–10 kHz), amplified (×10,000), 
digitized at 20 kHz using a 1401 interface [Cambridge Electronic Design (CED)], monitored 
online by an audio monitor (Grass AM10; Astro-med) and stored on a personal computer. Action 
potentials were analyzed using Spike2 software (CED). Action potentials were discriminated as 
single units based on principle component analysis of individual spike waveform. To avoid errors 
in discrimination, no more than two discernable active units in any record were studied. The fiber 
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stretch threshold (Tforce) was defined as the force that evoked the first action potential during a 
stretch stimulus (Feng et al., 2010; Feng and Gebhart, 2011). Latency (Ttime) was the time when 
the first action potential was fired. Analysis of firing rate (hertz) and instantaneous frequency (IF; 
average and peak) were done over the first 10 s from the first action potential. To ensure that light 
responses in sensory fibers were not due to laser generated heating of the tissue, similarly timed 
light exposures were done using preparations from littermate control mice. Light stimulation in 
controls did not produce action potential firing.  
2.2.8  Culture of primary colon epithelial cells 
Colon epithelial cells were acutely dissociated and cultured from the isolated distal colon. 
The longitudinal muscle layer was teased apart, stripped off, and the remaining tissue was digested 
with collagenase P (Sigma-Aldrich; 0.09 mg/ml dissolved in Eagle’s Essential Medium containing 
1% glutamine and 1% bovine serum albumin) for 20 min at 37°C, followed by 0.25% trypsin-
ethylenediamine acid solution for 10 min at 37°C. Tissue was then resuspended in Basal Medium 
Eagle containing 1% glutamine and 2% penicillin/streptomycin and mechanically dissociated with 
fire-polished Pasteur pipettes. Dissociated cells were plated on 15 mm glass coverslips and 
maintained at 37°C in 5% CO2. Patch-clamp recordings were performed after 2 h of incubation. 
2.2.9  Whole-cell patch-clamp electrophysiology 
Patch-clamp recordings were obtained from ChR2-expressing colon epithelial cells 
exposed to blue light. Coverslips with plated epithelial cells were transferred to a recording 
chamber bath maintained at 22°C in a solution containing the following (in mM): 117.9 NaCl, 4.7 
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KCl, 25 NaHCO3, 1.3 NaH2PO4, 1.2 MgSO4, 2.5 CaCl2, 11.1 D-glucose, 2 sodium butyrate, and 
20 sodium acetate. Patch pipettes (2–3 M𝛀) were fabricated from Corning 8161 glass tubing and 
filled with (in mM) 145.6 CsCl, 0.6 CaCl2, 2.0 EGTA, 15.4 glucose, and 5.0 Na-HEPES, pH 7.3. 
Currents were acquired from epithelial cells in whole-cell configuration using an Axopatch 200B 
patch-clamp amplifier (Molecular Devices) and digitized using an ITC-16 interface and Pulse 8.6.3 
software (InstruTECH/HEKA). Cells were visualized using an Olympus BX50 microscope with 
differential interference contrast optics. The currents were clamped at 70 mVand blue light was 
delivered from a mercury arc lamp and sustained for 5–7 s using a 40× water-immersion objective. 
2.2.10  Electromyographic recording of VMR to colorectal distension and light stimulation 
Visceral sensitivity to colorectal distension (CRD) and light stimuli was measured using 
protocols detailed previously (Christianson, Bielefeldt, Malin, & Davis, 2010; DeBerry, Saloman, 
Dragoo, Albers, & Davis, 2015; Sadler et al., 2017). Mice were anesthetized in an induction 
chamber and then moved to a nose cone administering 2% isoflurane (vaporized with 95% O2/5% 
CO2). An incision was made in the skin of the lower abdomen and two silver wires were implanted 
in the external oblique abdominal muscle and attached to a differential amplifier (A-M Systems). 
A grounding electrode was adhered to the tail using Signagel (Parker Laboratories). A custom-
made laser-balloon device was inserted through the anus. This device contains polyethylene tubing 
(diameter, 0.8 cm), enclosing an optical fiber (400 µm core; Thor Labs) connected to a 473 nm 
laser power source (Laserglow Technologies) with an inflatable 1 cm plastic balloon on one end. 
After electrode implantation and balloon insertion, the level of isoflurane was lowered to 1.5% 
and then lowered by 0.125% every 10 min, down to 0.8%. Toe-pinch reflex was tested as isoflurane 
was slowly lowered until mice were responsive to toe pinch but were not ambulating. Once a 
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steady level of anesthesia was reached, CRD testing began. CRD was produced by inflating the 
balloon with air from a compressed nitrogen tank equipped with a pressure regulator and a separate 
pressure monitor used to regulate the pressure inside of the balloon. EMG signals (indicative of 
VMR) were amplified, filtered, recorded using Spike2 software (CED), and saved to a PC. Initial 
60 mmHg distensions were delivered every 4 min until mice displayed consistent responses to 
CRD. An additional three distensions were then applied, at 10 s each, with a 4 min rest period in 
between. The laser stimulation was then applied three times, at 20 s each, with a 4 min break 
between stimuli. Colorectal responses were quantified by measuring the area under the curve 
(AUC) for the entire distension or laser period and then subtracting the baseline AUC before 
application of the stimulus. These measures were then normalized to baseline.  
2.2.11  Experimental design and statistical analysis 
For single-fiber experiments, the mean values measured in firing properties between two 
groups (e.g., TRPV1-ChR2 vs. Vil-ChR2, homozygous vs heterozygous mice, or non-stretch-
sensitive fibers and stretch-sensitive fibers) were compared using unpaired two-tailed t tests with 
p < 0.05. Analysis of distension and laser VMR data across control, TRPV1-ChR2, and Vil-ChR2 
groups was performed using nonparametric Kruskal–Wallis and Mann–Whitney tests. The number 
of animals used for each analysis and statistical values are reported in Results. All data were 
analyzed using Prism software (GraphPad). 
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2.3 Results 
2.3.1  Expression of ChR2-EYFP in colon ExPANs and colon epithelial cells 
We examined expression of the ChR2-EYFP fusion protein in DRG sensory neurons and 
distal colon epithelial cells using TRPV1-ChR2 and villin-ChR2 mice, respectively. Many ChR2-
YFP positive neurons were present in DRG of TRPV1-ChR2 mice (Figure 4A), including those 
with ExPANs that project to the colon (Figure 4B). Previous analysis of the TRPV1-Cre mouse 
line showed that transgene expression occurs in the majority of C-fibers and a subset of A𝛅 
ExPANs (Cavanaugh, Chesler, Jackson, et al., 2011). This distribution is broader than that seen 
for TRPV1 in wildtype adult DRG because many neurons express TRPV1 during embryonic 
development (which would activate the Cre recombinase) but downregulate expression postnatally 
(Cavanaugh, Chesler, Jackson, et al., 2011).  
In colon tissue of TRPV1-ChR2 mice, ChR2-EYFP-positive fibers were observed in 
muscular and mucosal layers of the organ (Figure 4B). TRPV1 expression has been reported in a 
subset of vagal afferents (Bielefeldt, Zhong, Koerber, & Davis, 2006; Patterson, Zheng, Ward, & 
Berthoud, 2003; Taylor-Clark et al., 2008) and thus, some of these endings could be vagal 
(Berthoud, Carlson, & Powley, 1991; Berthoud, Jedrzejewska, & Powley, 1990; F. B. Wang & 
Powley, 2000). In addition, there are reports of occasional TRPV1-expressing neurons in the 
myenteric plexus (Buckinx et al., 2013; Matsumoto et al., 2012) but in general, TRPV1-expressing 
neurons within the enteric nervous system are rare (Sharrad, Hibberd, Kyloh, Brookes, & Spencer, 
2015).  
Cre-recombinase expression, driven by the promoter of the actin binding protein villin, 
targeted ChR2 expression to epithelial lining cells of the colon (Figure 4C,D). YFP labeling 
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indicated expression occurred in all lining epithelial cells but not in other cell types within the 
colon (e.g., immune, vascular, mesenchymal), cells within the enteric nervous system, or DRG 
afferents (data not shown). To ensure epithelial cells were responsive to blue light, patch-clamp 
analysis of YFP-positive cells isolated from enzymatically dissociated colon was carried out. YFP-
labeled cells, but not unlabeled cells, showed membrane depolarization in response to blue light, 
indicating light-activation of the membrane localized ChR2 ion channel (Figure 4E–G).  
As colon tissue from homozygous mice showed higher levels of ChR2 mRNA relative to 
heterozygotes (determined using reverse transcriptase real time PCR) and this increase correlated 
with stronger physiologic responses (data below), the majority of experiments were conducted on 
mice homozygous for the ChR2 transgene. The number of Cre alleles did not affect the response 
to light-activation of ExPANs or epithelium. 
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Figure 4. Cell-specific expression of Cre recombinase targets ChR2 to sensory neurons and colon epithelium 
(A) ChR2-YFP (green)-positive neurons and fibers are present in the L6 DRG of TRPV1-ChR2 mice. (B) Low -power 
image shows distribution of ChR2-YFP in the distal colon of TRPV1-ChR2 mice. Arrows indicate nerve bundle in 
muscular layers and nerve fibers penetrating submucosal layers of the colon. (C) ChR2-YFP (green) expression in 
villin-ChR2 mice is confined to epithelial cells of the colon mucosal layer. Anti-PGP9.5 (yellow) labels nerve fibers 
that extend into mucosal regions and regions of nerve ganglia in the muscular layer (arrows). (D) High-power image 
illustrates close association between PGP9.5-positive nerve fibers (arrows) and ChR2-YFP labeled epithelial cells. (E, 
F) Patch-clamp analysis of dissociated YFP colon epithelial cells show production of inward currents (G) in response 
to 488 nm blue-light stimulation. YFP+ cell diameter diameters were ~5 µm. Calibration bars: A, D, F, 50 µm; B, E, 
200 µm; C, 20 µm; G, 50 pA, 1 s.  
2.3.2  ChR2-YFP expression does not change intrinsic firing properties of colon ExPANs 
A total of 207 colon ExPANs (light-responsive and non-light-responsive) were recorded 
from TRPV1-ChR2 (69 fibers) and villin-ChR2 (138 fibers) mouse lines. There were no obvious 
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effects of transgene expression on normal sensory responses (i.e., to brushing, probing, or 
stretching). For stretch, single colon ExPAN fibers in both TRPV1-ChR2 mice and villin-ChR2 
mice exhibited no significant difference in the IFavg in response to circumferential distension [firing 
(spike) frequency of TRPV1-ChR2 colon ExPANs, 4.74 ± 0.83 Hz (n = 28) vs. villin-ChR2 
ExPANs, 5.91 ± 0.66 Hz (n = 50); p = 0.28, t = 1.09]. 
2.3.3  Activation of ChR2 in colon ExPANs phenocopies responses to natural stimuli 
Electrophysiological recordings of teased fibers from the PN of TRPV1-ChR2 mice were 
used to compare colon ExPAN responses to blue light with their response to applied natural stimuli 
(blunt probing, stroking, stretch). The dissection and ex vivo preparation used for this analysis are 
described in Materials and Methods and Figure 5, A and B. Examples of single-fiber recordings 
for each ExPAN type are shown in Figure 5C. From 21 TRPV1-ChR2 mice (9 males, 12 females), 
recordings from 69 sensory fibers were obtained. Of these, 60 were blue light-sensitive, or 86%, 
which is virtually identical to the number of capsaicin responsive colon ExPANs reported from 
intracellular recording from L6 colon ExPANs (S. A. Malin et al., 2009). Among the light-
responsive fibers, 33 were stretch-sensitive whereas 27 were not (Figure 6A).  
We also noted that the IFavg in response to continuous blue light illumination (at least 10 s) 
was significantly higher in fibers from homozygous (n = 12) animals compared with their 
heterozygous (n = 38) littermates (homozygous 5.49 ± 1.31 Hz vs. heterozygous 3.3 ± 0.45 Hz; p 
= 0.05, t = 2.02), which suggests that increased expression and membrane insertion of the ChR2 
protein leads to enhanced ExPAN firing.  
ExPAN responses to blue light in TRPV1-ChR2 preparations produced variable firing 
patterns that were not unique to fiber type. Patterns ranged from firing in single or multiple bursts 
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to continuous tonic firing (Figure 5C). The average firing rate and latency to fire in response to 
light onset was similar for stretch and non-stretch-sensitive fibers [(IFavg = 3.8 ± 0.57 Hz (stretch-
sensitive, n = 28) vs. 3.86 ± 0.82 Hz (non-stretch-sensitive, n = 22); p = 0.95, t = 0.06; latency to 
first spike = 0.4 ± 0.17 s (stretch-sensitive, n = 27) vs. 0.28 ± 0.15 s (non-stretch-sensitive, n = 
20) p = 0.62, t = 0.5)].  
The ability of TRPV1-ChR2 fibers to follow pulsed blue light was also assessed at 1, 5, 
10, and 20 Hz in 24 fibers. All TRPV1-ChR2 fibers that did respond to light were able to fire 
action potentials at 1 Hz, but the number of action potentials decreased with increasing frequency. 
At 1 Hz, 86.4% of the 50 ms light pulses induced action potentials in all ExPANs. With increasing 
frequency this percentage decreased to 20.7% at 20 Hz (Table 1). This pattern was observed across 
all fiber types.  
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Figure 5. Examples of teased fiber recordings from TRPV1-ChR2 mice show activation of all fiber types in 
response to blue light. 
(A) Diagram illustrates the components of the ex vivo preparation used to obtain single-fiber recordings of colon 
ExPANs. (B) Image shows colon tissue with attached fat pad and pelvic nerve from which recordings were made. (C) 
All classes of mechanically sensitive colon ExPANs (mucosal, muscular, muscular/mucosal, and serosal) exhibited 
robust action potential firing in response to blue laser light. Scale bar, 4 mm. 
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Table 2. TRPV1-ChR2 fibers responses to 1, 5, 10, and 20 Hz light stimulation 
 1 Hz (n = 24) 5 Hz (n = 23) 10 Hz (n = 9) 20 Hz (n = 12) 
Light pulses that 
generate an action 
potential, % (avg) 
 
 
   
 
 
 
Figure 6. Distribution of blue light-responsive (LR) and non-light-responsive (NLR) fiber types in TRPV1-
ChR2 and villin-ChR2 mice 
(A) Of 69 sensory fibers recorded from TRPV1-ChR2 mice (N = 20 mice), 86% were responsive to blue light. Of the 
69 fibers, 39 were stretch-sensitive (muscular or muscular/mucosal) and 30 were not stretch-sensitive (mucosal and 
serosal). (B) For villin-ChR2 mice (N = 27 mice) a total of 138 fibers were characterized and of these, 50 (36%) were 
responsive to blue-light activation of colon epithelium. 
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2.3.4  Optogenetic activation of ChR2 in colon epithelial cells generates action potentials in 
colon ExPANs 
Using the ex vivo colon preparation we then determined the effect of light activation of 
ChR2 in epithelial cells on colon ExPAN firing. Teased fiber analysis of the pelvic nerve showed 
that blue light generated robust action potential firing in DRG sensory fibers, similar to responses 
elicited by stretch stimulation (Figure 7). Responses of teased fibers to mechanical or blue-light 
stimulation were recorded in preparations from 27 villin-ChR2 mice (14 males, 13 females; n = 
138 fibers). Comparison of response properties of light-sensitive and light-insensitive fibers 
showed no difference in the IFavg for circumferential stretch in stretch-sensitive ExPANs [light-
sensitive (n = 8; mean stretch IFavg = 4.52 ± 1.04) vs. light-insensitive ExPANs (n = 42; mean 
stretch IFavg = 6.18 ± 0.75, p = 0.36, t = 0.92)]. IFavg values for blunt probing were also similar 
between light-sensitive and light-insensitive serosal ExPANs (those ExPANs that did not respond 
to stretch but did respond to probing: light-sensitive, n = 9, mean probe IFavg = 21.76 ± 4.11 vs. 
light-insensitive, n = 13, mean probe IFavg 21.6 ± 3.52; p = 0.98, t = 0.03).  
The increased level of ChR2 mRNA in homozygous villin-ChR2 mice, as indicated by RT-
PCR measures, translated to increased fluorescent intensity of ChR2-EYFP expression in the 
colon. Colon preparations from homozygous villin-ChR2 mice also had a greater percentage of 
action potentials generated in response to epithelial activation; 50.5% of fibers recorded from 
villin-ChR2 homozygous mice (46/91) responded to light compared with 8.5% (4/47) in 
heterozygous mice.  
Of the 50 fibers that responded to light stimulation of colon epithelium, 39 were stretch-
sensitive (i.e., muscular and muscular/mucosal subtypes; Figure 6B). Evoked responses had a 
wide range of latencies (0.03 – 60.3 s, mean 15.5 ± 2.09 s; Figure 8B), and the majority of 
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responses exhibited robust firing that adapted over time. Comparison of stretch-sensitive and 
stretch-insensitive (serosal) ExPANs in which firing latency to light could be accurately measured, 
showed that action potentials elicited in stretch-sensitive fibers (n = 27) had shorter latencies 
(latency = 12.2 ± 1.98 vs. 24.03 ± 6.14, p = 0.02, t = 2.43) and higher IFavg values (5.37 ± 0.56 
vs. 3.13 ± 0.97, p = 0.058, t = 1.96) compared with non-stretch-sensitive fibers (n = 8).  
Interestingly, of the four types of extrinsic colon ExPANs, light activation of the epithelium 
produced robust action potential firing in all but mucosal ExPANs (Figure 6B). This was 
surprising given that this type of fiber, identified by its ability to respond exclusively to light 
brushing of the epithelium, is thought to terminate in or nearby the colonic epithelium and therefore 
should be in an ideal location to respond to activation of ChR2 in the epithelium. It should be noted 
that this anatomical relationship is only inferred based on stimulus response properties; there are 
no reports in which anatomical features have been determined for physiologically characterized 
ExPANs. Thus, mucosal fibers may communicate with the epithelium in a manner that is unique 
from other types of ExPANs (and one not engaged by ChR2 activation) and/or their ability to 
respond to brushing of the epithelium is via mechanical sensory transducers intrinsic to this 
population of ExPANs in a manner that does not rely on communication with the epithelium.  
ExPAN firing rates in response to light stimulation of epithelial cells was similar to rates 
recorded from TRPV1-ChR2 ExPANs [mean villin: IFavg = 4.86 ± 0.5 Hz (n = 35) vs. TRPV1: 
3.83 ± 0.48 Hz (n = 50), respectively; p = 0.15, t = 1.46]. However, there was a significantly longer 
latency for the first action potential with light-activation of villin-ChR2 epithelial cells than that 
measured for light activation of TRPV1-ChR2 ExPANs [latency: villin 14.9 ± 2.2 s (n = 35); 
TRPV1 0.35 ± 0.12 s (n = 47); p < 0.0001, t = 7.67; compare Figures 5C and 7]. In addition, the 
latency of ExPAN firing in villin-ChR2 mice increased with repeated light stimulation.  
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Interestingly, when comparing afferent firing induced by light activation of epithelial cells 
to that induced by natural stimuli (stretch) in the same fiber, the latencies to first action potential 
were not significantly different [stretch-sensitive fibers (n = 8), latency in response to light = 4.73 
± 1.07 s; latency in response to stretch = 4.52 ± 1.04 s, p = 0.89, t = 0.14]. This suggests that the 
mechanism(s) underlying epithelial activation of colon ExPANs shares temporal characteristics 
with those for stretch induced activation. Thus, epithelial activation could be a contributor to 
stretch-induced ExPAN activation.  
 
 
Figure 7. Examples of teased fiber recordings from villin-ChR2 mice show activation of all fiber types in 
response to blue light 
With the exception of mucosal ExPANs, all classes of mechanically sensitive colon ExPANs are blue light-sensitive. 
In the example provided for serosal ExPANs, two fibers were recorded together. One fiber was classified as serosal 
and light responsive, due to its responses to probe and laser stimulation (1). A second fiber was sensitive to stretch 
stimulation but not light (2). The two different fibers are apparent in the bottom trace, where stretch and laser are 
applied at the same time.  
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Figure 8. ExPAN of TRPV1-ChR2 and villin-ChR2 mice have different latencies to blue-light stimulation. 
(A) Nearly all mechanically sensitive ExPANs from TRPV1-ChR2 mice had firing latencies (time between start of 
light stimulus and ExPAN firing) <1 s (avg = 0.35 s). Inset, Log plot of values on an expanded scale. (B) Mechanically 
sensitive fibers from villin-ChR2 mice exhibit much longer latencies (avg = 14.9 s) in response to light activation of 
the epithelium. Mucosal fibers that respond to light activation were rare compared with all other fiber types. 
2.3.5  Antagonism of ATP signaling inhibits stretch- and light-induced ExPAN firing 
The increased latency of firing in generation of action potentials by light-mediated 
activation of epithelial cells suggests that communication to nerve fibers occurs through release of 
a chemical mediator(s). To explore this possibility, we bath applied an ATP antagonist drug 
mixture (PPADS, TNP-ATP, and AR-C118925XX) to the preparation and assessed firing 
properties. In response to a ramp stretch stimulus, 4 of 6 (66.7%) TRPV1-ChR2 stretch-sensitive 
fibers had reduced responses in the presence of drug mixture (Figure 9A). No fibers showed 
complete inhibition of firing with drug application. The ability of the ATP antagonist mixture to 
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block the response to light stimulation of the epithelium was also tested in 11 fibers of villin-ChR2 
mice. Of these, 8 (72.7%) responded to drug application, which is comparable to the inhibitory 
effects on the TRPV1-ChR2 stretch-sensitive fiber population (Figure 9B). All fibers tested were 
stretch-sensitive. Of the eight drug-sensitive fibers, 37.5% (3/8) had a complete block in firing, 
whereas 62.5% (5/8) had a partial block to drug application.  
 
 
Figure 9. Antagonism of ATP signaling causes reduction in firing to stretch and light stimuli 
A drug mixture containing PPADS, TNP-ATP, and AR-C118925XX was used to block responses to stretch (A) or 
laser (B) stimuli. Response to the drug mixture was defined as a ≥25% reduction in average firing rate upon drug 
application and a recovery of firing rate by ≥25% upon washout. Gray dotted lines in each graph represent 
nonresponders. (A) Fiber responses to stretch were recorded at baseline, in the presence of the antagonist mixture, 
and after a 10 min washout. Four of six fibers tested (66.7%) responded to the antagonist mixture and showed 
reduction in spike frequency in response to stretch. (B) In villin-ChR2 mice, fibers that were identified as stretch-
sensitive were also evaluated. Fiber responses to laser stimulation of colon epithelium were recorded at baseline, in 
the presence of the antagonist mixture, and after a 10 min washout. Application of the ATP antagonist mixture 
caused a reduction in firing frequency to light in 8 of the 11 fibers tested (72.7%).  
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2.3.6  Light activation of colon epithelium elicits behavioral responses 
To determine whether activation of ChR2 in colon epithelial cells engages neural signaling 
pathways in vivo, we assessed behavioral responses to colon distention and light activation in 
anesthetized animals. Measures of the VMR were obtained as a surrogate for sensory-induced 
activation of the colon neural circuitry. Colon distension, via computer-controlled inflation of a 
balloon in the distal colon, was combined with laser illumination of the colon via a fiber optic 
contained within the balloon. In littermate control mice (4 males, 2 females), balloon distension to 
60 mmHg induced a strong VMR response (Figure 10A) but no change in VMR in response to 
light illumination of the colon (Figure 10B). As a positive control for ChR2 activation of sensory 
neurons, TRPV1-ChR2 mice were tested (1 male, 3 females). As expected, TRPV1-ChR2 mice 
exhibited a strong VMR in response to light activation similar to that evoked with balloon 
distention of the colon (Figure 10C). For Vil-ChR2 mice (4 males, 1 female), light activation of 
ChR2 in the epithelium also produced robust and reproducible VMRs (Figure 10D). Comparison 
of the response rate to light stimuli shows that relative to control littermates (n = 6 mice), a 
significant increase occurs in the percentage of responses for both TRPV1-ChR2 (p = 0.005, n = 
4) and Vil-ChR2 (p = 0.038, n = 5) groups. There was no difference in the percentage of response 
between TRPV1-ChR2 and Vil-ChR2 groups (Figure 10E). The average VMR values for the 
TRPV1-ChR2 and Vil-ChR2 groups also were significantly greater relative to the control group 
(TRPV1-ChR2, p = 0.006; Vil-ChR2, p = 0.043; Kruskal–Wallis test), but there was no difference 
between the two ChR2-expressing mouse lines (Figure 10F). 
Finally, though the response rates were not significantly different between the TRPV1 and 
Vil-ChR2 groups, the latency to respond was significantly faster in TRPV1-ChR2 mice [latency 
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Vil-ChR2, 7.9 ± 1.9 s (n = 6 mice) vs. TRPV1-ChR2, 0.31 ± 0.2 s (n = 4 mice); p = 0.010, t = 
3.957; unpaired t test with Welch’s correction]. This difference well parallels the increased latency 
of firing measured using the teased fiber preparation and likely reflects the more direct activation 
of ChR2 in ExPAN terminals versus the epithelium. 
 
 
 
 
 
 
 
 
 52 
 
Figure 10. In vivo light-mediated activation of colon epithelium generates visceromotor responses 
(A) Visceromotor responses (VMRs) to noxious colon distention (60 mmHg) were elicited in all mouse strains 
analyzed: Vil-ChR2, TRPV1-ChR2 and littermate controls. Example shown is a recording from a control mouse. (B) 
In control mice, blue-light stimulation produces no VMR in response. (C) In TRPV1-ChR2 mice, blue-light activation 
of ChR2 expressed in colon ExPANs elicits VMRs comparable to those measured using 60 mmHg of balloon pressure. 
(D) Vil-ChR2 mice exhibit robust VMRs in response to blue-light stimulation of ChR2 expressed in epithelial cells. 
(E) Plot shows percentage of VMR responses per animal obtained in response to light stimulation of the colon (n = 4 
TRPV1 mice, n = 5 Vil-ChR2 mice, and 6 littermate controls). There was no difference in response rate between 
TRPV1- and Vil-ChR2 groups. (F) Plot shows average VMR values obtained from TRPV1-ChR2 (n = 4), Vil-ChR2 
(n = 7), and control (n = 6) groups. Values were obtained by normalizing to baseline measures from individual animals. 
Asterisks indicate significant increases relative to control group for TRPV1- and Vil-ChR2 groups. There was no 
difference in VMRs between TRPV1- and Vil-ChR2 groups. 
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2.4 Discussion 
Results from this study show that ChR2-mediated activation of colon epithelium can 
directly engage neural circuitry involved in regulating neural pathways critical for colon function. 
Results of teased fiber analysis of an intact colon preparation and in vivo measures of VMRs in 
response to light stimuli indicate that selective activation of epithelial cells generates action 
potentials in ExPANs that have functional consequences. Epithelial–nerve communication was 
evident across all functional subtypes of colon ExPANs with the exception of mucosal ExPANs. 
The absence of this fiber type may be due to the small number of mucosal sensory neurons sampled 
by our study (6 of 138 total fibers). The response parameters of sensory fibers activated by 
light/epithelial stimulation were often similar to those elicited by mechanical stimulation (designed 
to mimic natural stimuli). Importantly, the neuronal response to light stimulation of epithelial cells 
could be blocked or diminished in the majority of responsive sensory fibers with the application 
of a mixture of ATP receptor antagonists. These results indicate that the intestinal epithelium 
alone, e.g., without additional mechanical stimuli, can directly activate colon ExPANs and that 
ATP is likely to have a critical role in this epithelial cell–nerve communication.  
Light activation of epithelial cells was sufficient to cause firing in ExPANs functionally 
classified as muscular, muscular/mucosal, and serosal. Because fiber classifications were made 
based on responses to stroking, probing, and stretch, as is standard in the field, the exact anatomical 
location of these endings is not known. For example, anatomical tracing studies (X. Song et al., 
2009; Spencer et al., 2014) find no evidence of fibers that actually end in the serosa, making the 
terminology misleading. This makes it difficult to accurately define a mechanistic link between 
epithelial activation and firing in ExPAN types, e.g., muscular and serosal. With this limitation in 
mind, one mechanism of activation could involve an intermediary cell; for example, a neuron in 
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the submucosal and/or myenteric plexus that has projections near the epithelium. In this scenario, 
the location of a responsive ExPAN relative to the epithelium would not matter, provided that it 
connects with another neuron(s) that is near the mucosa. A synaptic delay might, in part, explain 
the longer latency to firing that follows laser exposure when ChR2 is expressed in the epithelium 
compared with when it is expressed within the sensory fiber itself. There is also the question as to 
whether a response to brushing really means that the fiber is terminating at the mucosa. It is entirely 
possible that this response simply represents a colon ExPANs with a very low mechanical 
threshold whose termination could be in more distant layers.  
The epithelium has long been implicated as a modulator of neural activity. A recent 
example comes from Bellono et al. in which application of norepinephrine to the mucosa was 
shown to induce action potential firing in mucosal ExPANs that could be blocked by 5-HT3 
receptor antagonism. Bellono et al. also showed that a subset of colon epithelial cells, 
enterochromaffin cells, which are electrically excitable, express voltage-gated ion channels and 
release 5-HT in response to depolarization (Bellono et al., 2017).  
Of particular relevance for the present work is the purinergic mechanism hypothesis, in 
which Burnstock proposed that intestinal epithelial cells release endogenous ATP in response to 
stretch. This hypothesis proposed that released ATP activates P2X3 or P2X2/3 receptors localized 
on ExPAN terminals, resulting in increased firing (Burnstock, 1999, 2001, 2013). Using an ex vivo 
preparation of rat colorectum, Wynn et al. provided support for this hypothesis by showing that 
serosal application of ATP could activate mechanosensitive ExPANs, increasing their peak 
responses (Wynn et al., 2003). However, missing from these previous studies is direct evidence 
that activation of the colonic epithelium can produce action potentials de novo in extrinsic primary 
sensory neurons, e.g., without simultaneous mechanical stimuli. Until the advent of optogenetic 
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tools these data have been difficult to obtain since it was not possible to stimulate colonic 
epithelium without also engaging putative transduction mechanisms resident in sensory fibers 
themselves, i.e., because of the intimate anatomical relationship of the colonic epithelium and the 
nerves innervating these cells, mechanical, chemical, or thermal stimulation could not be applied 
without simultaneously affecting both compartments. The selective expression of opsin genes by 
tissue-specific gene promoters as used here allows specific activation of epithelial cells. As seen 
in cutaneous sensory neurons (Baumbauer et al., 2015), light activation of ChR2 expressed in colon 
ExPANs (i.e., in TRPV1-ChR2 mice) did not completely mimic the response to naturalistic colon 
stimuli (i.e., stretch or probing).  
As in cutaneous afferents, light activation of ChR2 in colon ExPANs produced almost 
instantaneous action potentials and continuous exposure to 473 nm light produced repetitive firing 
with relatively stable instantaneous frequency (although desensitization was seen at longer 
exposure times). This pattern of action potential firing differs from the patterns observed when 
action potentials were induced by light activation of the colon epithelium; for epithelium, neuronal 
firing patterns were much more complex and often similar to those produced by mechanical 
stimulation of the colon. These more complex patterns of neuronal activation included variable 
delays in the onset of firing, which were comparable to delays that occur during the induction of 
circumferential stretch and included high-frequency bursting and desensitization. The relatively 
long delay in ExPANs activation following light stimulation of the epithelium may reflect multiple 
factors. First, the intestinal epithelium is constantly moving upward from the stem-cell zone in the 
crypts toward the lumen as part of the dynamic process of epithelial cell turnover (J. J. Chen et al., 
2001; Heath, 1996). As a result, the anatomic relationship between the epithelial cells and the more 
static neuronal terminals varies at any given point in time (J. J. Chen et al., 2001) making it likely 
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that any neuromodulatory substance released by epithelial cells may have significant distances to 
diffuse before encountering neurotransmitter receptors on sensory endings. Another possibility is 
that epithelial activation releases activators that stimulate other cells in colon tissue, including 
immune cells or neurons in the enteric nervous system, that subsequently release neurotransmitters 
that activate colon ExPANs.  
As previous data show that epithelial-released ATP may modulate colon ExPAN activity 
(Ueda et al., 2009; Wynn et al., 2003), we further investigated epithelial–nerve signaling by 
combining ATP antagonists with light stimulation of the epithelium. As a positive control, we 
were able to confirm that ATP is involved in modulation of action potentials in colon ExPANs in 
response to physiologic stretch by demonstrating that ATP receptor antagonists reduce firing 
during a ramp stretch. A similar decrease in firing was seen when the same ATP antagonists were 
combined with light activation of ChR2-expressing epithelial cells, supporting the hypothesis that 
colonic epithelium can directly initiate action potentials in colon ExPANs via the release of ATP. 
It should be noted that although some epithelial-induced firing of colon ExPANs was completely 
blocked by our ATP antagonist mixture, most fibers exhibited only partial reduction in firing. This 
suggests that additional mechanisms are likely involved in neuronal activation. In addition, our 
drug mixture of ATP antagonists targeted ATP receptors known to be expressed in colon ExPANs, 
including P2X2/3 and P2Y2 (Brierley et al., 2005; Giaroni et al., 2002; Robinson, McNaughton, 
Evans, & Hicks, 2004; Shinoda, La, Bielefeldt, & Gebhart, 2010). However, Hockley et al. 
recently described the expression of additional P2Y receptors including P2Y1, P2Y4, P2Y12, and 
P2Y13 on colon ExPANs (although P2Y12, and P2Y13 are Gi/o GPCRs and therefore likely to be 
inhibitory). Hockley et al. found that P2Y1, an excitatory receptor that binds ADP (a rapid 
metabolite of ATP) and UTP, was expressed in a majority of dissociated colon sensory neurons (J. 
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R. Hockley et al., 2016). Our studies used PPADS, but at a concentration that may not completely 
block P2Y1, and therefore, some of the ExPAN activity not blocked following ChR2 activation of 
the epithelium could be due to binding of either ADP or UTP to P2Y1 expressed on colon ExPANs. 
Also to be considered is that colon ExPANs express several additional ligand-mediated excitatory 
channels including TRPV1 (Brierley et al., 2005; S. Malin et al., 2011; S. A. Malin et al., 2009; 
Matsumoto et al., 2009; Sugiuar, Bielefeldt, & Gebhart, 2004), TRPA1 (Brierley et al., 2009; 
Christianson et al., 2010; Engel et al., 2011; S. Malin et al., 2011), TRPM8 (Mueller-Tribbensee 
et al., 2015), and 5-HT3 and 5-HT4 receptors (Coldwell, Phillis, Sutherland, Howarth, & 
Blackshaw, 2007; Feng, La, Schwartz, & Gebhart, 2012; Gershon, 2013; Hicks et al., 2002; Mawe 
& Hoffman, 2013).  
The present study fills a major gap in the purinergic hypothesis in that it shows using an 
intact preparation that it is possible to stimulate colonic epithelium without stimulating any 
surrounding cells, including neurons. This stimulation produces robust firing of colon extrinsic 
sensory neurons in a manner that is at least partially ATP dependent. However, numerous 
questions remain. Studies by Bohorquez et al. (Bohorquez, Chandra, Samsa, Vigna, & Liddle, 
2011; Bohorquez et al., 2014) have revealed molecular and anatomical specializations typically 
present at synapses (including dense and clear core vesicles) in unique populations of 
neuroendocrine cells in the colon and that these specializations are found adjacent to colon 
ExPANs. Although these cells represent a minority of colonic epithelial cells, they provide a 
“proof of concept” for the type of structure that could be responsible for the epithelial based 
activation of colon ExPANs described here. However, it is important to note that other authors 
provide evidence that stretch-evoked activation of colon ExPANs is Ca2+-independent 
(Zagorodnyuk, Lynn, Costa, & Brookes, 2005), indicating that vesicular release (which is typically 
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Ca2+-dependent) is not an essential requirement for mechanotransduction. Thus, further work is 
necessary to identify the mechanism underlying epithelial–nerve communication and to better 
understand the role of the colon epithelium in modulation of colon ExPANs activity under normal 
and pathological conditions. 
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3.0 Optogenetic Inhibition of Colon Epithelium Reduces Hypersensitivity in a Mouse 
Model of Inflammatory Bowel Disease 
3.1 Introduction 
In the gut, extrinsic primary afferent neurons (ExPANs) convey mechanical and chemical 
stimuli to neurons in the central nervous system (Brierley et al., 2018). In response to inflammatory 
and other pathophysiological changes in the gut, sensory afferents can become sensitized. 
Evidence suggests this sensitization significantly contributes to the chronic pain and decreased 
quality of life that accompany inflammatory bowel disease conditions (IBD; e.g., Crohn’s disease 
(CD) and ulcerative colitis (UC)) (Bielefeldt, Lamb, & Gebhart, 2006; Farrell, Callister, & Keely, 
2014; S. A. Malin et al., 2009; Mawe & Hoffman, 2013). 
While there is evidence to suggest that the intrinsic changes in ExPANs underlies the 
increase in excitability observed following inflammation (Azpiroz et al., 2007; Gold & Gebhart, 
2010; Gold & Traub, 2004; Gold, Zhang, Wrigley, & Traub, 2002), a growing body of evidence 
suggestions changes in other cell types may also contribute to this process. Colon epithelial cells 
are one of these cell types. The epithelium not only maintains the mucosal barrier, but also 
synthesizes and releases neurotransmitters such as adenosine triphosphate (ATP) and 5-
hydroxytrypamine (5-HT/serotonin) (Najjar, Davis, & Albers, 2020). The spatially- and 
temporally-controlled release of these neurotransmitters is thought to facilitate communication 
between the epithelial lining and ExPAN terminals (Bertrand, 2009; Latorre et al., 2016), 
supporting an important role for the epithelium in regulating primary afferent activity and 
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nociceptive responses (Baumbauer et al., 2015; Bellono et al., 2017; Makadia et al., 2018; Moore 
et al., 2013; Pang et al., 2015; Sun et al., 2001).  
In the context of IBD, most studies of epithelial cells have focused on a failure of the 
epithelium to maintain a barrier, enabling bacterial infiltration and ExPAN sensitization secondary 
to the resulting immune responses (Peterson & Artis, 2014; Roda et al., 2010). However, with 
evidence of a direct role in pain signaling, it is possible that the epithelium contributes to persistent 
ExPAN sensitization. Studies in animal models as well as in colon tissue from IBD patients suggest 
that inflammation affects enteroendocrine cell signaling (Lomax, Linden, Mawe, & Sharkey, 
2006), thus it is possible that inflammation changes normal communication between the epithelium 
and ExPANs. This may contribute to the sensitization of ExPANs and consequently the pain and 
hypersensitivity associated with IBD. To begin to address this possibility we tested whether 
optogenetic-mediated inhibition of the epithelium alters nociceptive signaling. We examined 
epithelial-sensory afferent communication under normal and inflamed conditions using a mouse 
model in which the inhibitory, yellow light activated archaerhodopsin (Arch) protein was targeted 
to epithelial cells. Colon sensitivity was assessed using the visceromotor response (VMR) to 
colorectal distension (CRD) measured with and without the light-induced inhibition of epithelial 
cells. We measured the efficacy of Arch-mediated inhibition of epithelial cells in reducing the 
VMR to CRD and then compared these results to those obtained in parallel using mice that express 
Arch in transient receptor potential vanilloid 1 (TRPV1)-lineage ExPANs. Results show that 
inhibition of the colon epithelium is effective in reducing inflammation-induced hypersensitivity. 
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3.2 Methods 
3.2.1  Animals 
Male and female mice aged 6-8 months were analyzed. Two mouse lines were used: Vil-
Arch, in which the inhibitory opsin ArchT was targeted to intestinal epithelium, and TRPV1-Arch, 
in which ArchT was targeted to primary afferent neurons innervating the colon. ArchT, an 
archaerhodopsin from Halorubrum strain TP009, is a yellow light driven outward proton pump 
that causes cellular hyperpolarization (Han et al., 2011).  
Mice with an ArchT-EGFP fusion protein in the Rosa26 locus (Ai40D mice; RRID: 
IMSR_JAX:021188) were crossed with villin-Cre mice (RRID: IMSR_JAX:004586) and TRPV1-
Cre mice (RRID:IMSR_JAX:017769). Littermates with Cre only or ArchT-EGFP only were used 
as controls. Animals were housed in an AAALAC-approved facility and handled in accordance 
with protocols approved by the University of Pittsburgh Institutional Animal Care and Use 
Committee. 
3.2.2  Laser-balloon device construction 
To enable balloon distension simultaneous with optogenetic stimulation a 100-cm optical 
fiber (400 µm core with 1.25 mm ceramic ferrule and 440 µm FC/PC connector; Thor Labs, 
Newton, NJ) was threaded through a 15-cm piece of PE-200 polyethylene tubing connected to a 
3-way stopcock (Makadia et al., 2018). To make the balloon, a 3 cm x 3 cm piece of Saran wrap 
was secured around the tubing using silk sutures (Ethicon, Somerville, NJ). The balloon length 
was 1.5 cm and when inflated, its diameter was 0.9 cm. The fiber optic was attached to a 589 nm 
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laser and power source (Laserglow Technologies, Toronto, ON, Canada). The laser power 
measured when illuminated through the plastic balloon was 12 mW/mm2.  
3.2.3  Electromyographic recording of visceromotor responses 
Mice were fasted overnight and anesthetized using an intraperitoneal injection of urethane 
(Sigma; 1.2 g/kg). Mice were then placed on a heating pad and into a nosecone attached to an 
isoflurane vaporizer delivering 1% isoflurane (vaporized with 95% O2/5% CO2) (Parkland 
Scientific, Coral Springs, FL). The lower left quadrant of the abdomen was shaved, and a 1.5-cm 
incision was made in the skin, revealing abdominal musculature. Two clip electrodes (Pomona 
Electronics, Pomona, CA) were attached to the abdominal muscle, approximately 3 mm apart, to 
enable electromyographic (EMG) recording. The laser-balloon device was inserted into the 
colorectum and secured with tape to the tail. A ground electrode was secured with SignaGel 
(Parker Laboratories, Fairfield, NJ) to the mouse’s tail. Electrodes were attached to a differential 
amplifier (A-M Systems, Sequim, WA) connected to an A-D converter (Micro 1401, Cambridge 
Electronic Design (CED), Cambridge, UK). EMG signals were amplified (10,000x), filtered (0.3-
10 kHz band pass), and sampled at 20 kHz with the 1401 interface. Signals were recorded using 
Spike2 software (CED) and saved to a PC. Colorectal distension (CRD) was performed by balloon 
inflation using a compressed N2 tank equipped with a pressure regulator and connected to an air 
valve box enabling computer control. Prior to testing isoflurane level was slowly lowered to 
0.25%. Mice were held at this level of combined anesthesia (isoflurane with previous urethane 
injection) until they showed no signs of ambulation but were responsive to toe pinch. After the 
mice displayed consistent responses to 60 mmHg CRD, the stimulus protocol was administered. 
This consisted of 3-5 trials of 10 s 60 mmHg CRD, followed by 3-5 trials of 10 s 60 mmHg CRD 
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plus yellow laser; laser was turned on 1 s before the distension stimulus and remained on 
throughout the 10 s stimulus. All stimuli were delivered at 4-min intervals. EMG waveforms were 
rectified in Spike2 and the integral of the waveform was used to quantify VMRs. The resting 
activity 10 s before distension was subtracted from the distension-evoked activity. EMG waveform 
extraction and data analysis were performed in a blinded manner. 
3.2.4  Dextran sulfate sodium inflammation protocol 
DSS was administered in drinking water. A 3% DSS solution was prepared by dissolving 
DSS (36,000-50,000 MW; MP Biomedicals, Santa Ana, CA) into autoclaved water that was 
provided ad libitum via water bottle for 5 days. Vehicle control mice were provided water without 
DSS. VMR analysis was performed immediately after 5 days of DSS treatment. 
3.2.5  Fluorescent microscopy and histopathological scoring 
Distal colon segments and L6 DRGs were isolated and fixed in 4% paraformaldehyde for 
at least 30 min. Tissues were cryopreserved in 25% sucrose overnight, embedded in optimal 
cutting temperature (OCT) compound, and sectioned at 14 µm thickness. Sections were 
coverslipped and EGFP expression imaged using a Leica DM4000B microscope equipped with a 
Leica DFC7000 T digital camera.  
DSS- and vehicle-treated mice were euthanized with isoflurane after VMR experiments. A 
1-cm piece of colon was removed and fixed for at least 30 min in 4% paraformaldehyde in 0.01 M 
phosphate-buffered saline (PBS) and cryoprotected in 25% sucrose in PBS at 4°C for 24 hours. 
The tissue was embedded in optimal cutting solution (OCT), sectioned on a cryostat at 14 μm, and 
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mounted on microscope slides. Sections were stained with hematoxylin and eosin (H&E) and 
brightfield images obtained using a Leica DM4000B microscope with a digital camera attachment. 
For disease scoring, a modified method of histopathological analysis was used (Kim, 
Shajib, Manocha, & Khan, 2012) The extent of damage to the tissue was determined by goblet cell 
depletion (0 = absent, 2 = severe), inflammatory cell infiltration (0 = normal, 2 = dense), and 
thickening of the submucosal layer (0 = base of crypt sits on muscularis mucosa, 2 = marked 
muscle thickening present). The disease score is the sum of the scores from each of these three 
categories, with a max score of 6 signifying greater pathological damage to the colon tissue. The 
experimenter determining disease scores was blinded to the treatment the mice received (DSS vs. 
vehicle). 
3.2.6  Data analysis 
Statistical analyses were performed using Prism (GraphPad Software, San Diego, CA). For 
VMR experiments, mice received 3-5 trials of 60 mmHg CRD to establish baseline responses and 
then 3-5 trials of 60 mmHg CRD + Laser. Trials with laser were considered inhibited when there 
was a significant (>2 standard deviations) decrease in VMR from mean baseline responses. 
Comparisons between Vil-Arch and TRPV1-Arch mice that displayed yellow-light induced 
inhibition in VMR (i.e., “responders”) were performed using 2-way ANOVA and Mann-Whitney 
tests. Histopathological scores and spleen weights of the DSS-treated colons were compared to 
vehicle-treated colons using unpaired t-tests. VMR to CRD at various pressures was tested in DSS-
treated and untreated mice using a two-way ANOVA. Statistical tests are specified in the results 
section and significance was defined as p < 0.05. Data are plotted as mean ± standard error of the 
mean. 
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3.3 Results 
3.3.1  Optogenetic inhibition of colon epithelial cells reduces VMR to CRD 
To enable specific inhibition of the colon epithelium, the yellow light-activated proton 
pump Arch was expressed under control of the villin-Cre driver. In Vil-Arch animals, Arch is 
fused to enhanced green fluorescent protein (EGFP), enabling visualization of the fusion protein 
in the villin-positive lining epithelial cells of the colon (Figure 11A). Arch-EGFP expression was 
restricted to the colon epithelium and not present in the L6 DRG (Figure 11B). A laser-balloon 
device was constructed to enable colorectal distension (CRD) simultaneous with light illumination 
of the colon lumen (Figure 11C). Visceromotor responses (VMR) to CRD were recorded, as they 
provide a reliable indication of visceral nociception (Christianson & Gebhart, 2007). VMRs to 
noxious distension (3-5 trials of 60 mmHg CRD) were recorded in Vil-Arch and control littermate 
mice before (baseline) and during yellow light application (Figure 11D). Out of 7 Vil-Arch mice, 
4 displayed inhibition with yellow light. Inhibition was defined as VMR <2 standard deviations 
from average baseline responses. In the CRD trials that were inhibited, yellow light reduced the 
VMR by 67 ± 19% (VMR to CRD baseline: 2.67 ± 0.72 V*s vs. VMR to CRD + laser: 1.14 ± 0.88 
V*s; Figure 11E). This inhibition occurred in an average of 66% of CRD + laser trials; Figure 
11E inset). The remaining 3 Vil-Arch mice that were tested did not exhibit a decrease in VMR in 
response to light stimulation that met our threshold of <2 standard deviations from average 
baseline responses (VMR to CRD baseline: 1.4 ± 0.52 V*s vs. average VMR to CRD + laser: 1.39 
± 0.60 V*s; Figure 11F). The littermate control mice (n = 5) did not display inhibition with yellow 
light in any trial (VMR to CRD baseline: 1.65 ± 0.27 V*s vs. average VMR to CRD + laser: 1.71 
± 0.32 V*s; Figure 11G).  
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Figure 11. Inhibition of the colon epithelium reduces visceromotor responses VMR to CRD 
Inhibitory opsin archaerhodopsin (Arch) is conjugated to enhanced green fluorescent protein (EGFP) to enable 
visualization. Arch-EGFP (green) is specifically expressed in colon epithelial cells under the villin-cre driver (A) 
and not in the L6 dorsal root ganglion (DRG) (B). (C) A laser-balloon device was constructed to enable colorectal 
distesion (CRD) simultaneous with light illumination of the colon lumen. (D) Visceromotor responses (VMRs) to 60 
mmHg CRD were recorded in villin-Archaerhodopsin (Vil-Arch) and control littermate mice before (Baseline) and 
during yellow light application (+ Laser). (E) Out of 7 Vil-Arch mice, 4 displayed a significant decrease in VMR to 
CRD with the addition of yellow light, which occurred in an average of 66% of trials (inset). (F) In the remaining 3 
Vil-Arch mice that were tested, none of the CRD + Laser trials met the threshold for a decrease. (G) Littermate 
control mice (n = 5) did not display inhibition with yellow light in any trial. Scale bars = 100 𝜇M (A), 50 𝜇M (B). 
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3.3.2  Optogenetic inhibition of colon ExPANs reduces VMR to CRD 
For comparison, I next measured changes in distension-induced VMRs due to yellow light 
stimulation in TRPV1-Arch mice. In these experiments, Arch was targeted to colon extrinsic 
primary afferent neurons (ExPANs) using the TRPV1-Cre driver, as TRPV1 is expressed in nearly 
90% of colon afferents (S. A. Malin et al., 2009). Arch-EGFP expression was observed in nerve 
terminals in the colon (Figure 12A) and in cell bodies in the DRG (Figure 12B). VMRs to 60 
mmHg CRD were recorded in TRPV1-Arch and control littermate mice before and during yellow 
light stimulation (Figure 12C). The same criteria were employed to identify mice responsive to 
light stimulation. Out of 6 TRPV1-Arch mice, 4 responded to yellow light stimulation. In the trials 
in which CRD was inhibited, yellow light reduced the VMR by 84 ± 8% (VMR to CRD baseline: 
1.22 ± 0.12 V*s vs. VMR to CRD + laser: 0.18 ± 0.08 V*s; Figure 12D). This inhibition occurred 
on average in 82% of trials (Figure 12D inset). The remaining 2 TRPV1-Arch mice did not 
respond to yellow light (Figure 12E). In the control littermate mice (n = 4), no reduction in VMR 
in response to light stimulation was observed (baseline VMR to CRD: 1.84 ± 0.23 V*s vs. average 
VMR to CRD + laser: 1.82 ± 0.33 V*s; Figure 12F). When comparing the Vil-Arch and TRPV1-
Arch mice that responded to yellow light, there was no statistical difference between groups in 
either were detected in the extent of inhibition in which a response was detected [main effect of 
yellow light (p = 0.01), no effect of genotype (p = 0.16); 2-way ANOVA; Figure 12G] or in the 
percentage of trials in which inhibition was detected (p = 0.57; Mann-Whitney test; Figure 12H). 
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Figure 12. Inhibition of colon extrinsic primary afferent neurons reduces VMR to CRD 
Inhibition of colon extrinsic primary afferent neurons reduces visceromotor responses (VMR) to colorectal distention 
(CRD). (A) Archaerhodopsin-enhanced green fluorescent protein (Arch-EGFP) was targeted to colon afferents using 
the transient receptor potential vanilloid 1 (TRPV1)-cre driver. Arch-EGFP-positive nerve terminals are found in the 
distal colon. (B) Arch-EGFP-positive (green) nerve cell bodies are present in the L6 dorsal root ganglion (DRG). (C) 
VMRs to 60 mmHg CRD were recorded in TRPV1-Arch and control littermate mice before (Baseline) and during 
yellow light illumination (+ Laser). (D) Out of 6 TRPV1-Arch mice, 4 displayed a significant decrease in VMR to 
CRD with the addition of yellow light, which occurred in an average of 82% of trials (inset). (E) The remaining 2 
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TRPV1-Arch mice did not display yellow light-induced reduction in VMR. (F) In the control littermate mice (n = 4), 
no reduction in VMR in response to yellow light was observed. (G) In comparing the Vil-Arch and TRPV1-Arch mice 
that responded to yellow light (n = 4 per group), no statistical differences were detected in the extent of inhibition in 
responding trials [main effect of yellow light (p = 0.01), no effect of genotype (p = 0.16); 2-way ANOVA]. (H) There 
was also no significant difference in the percentage of inhibited trials in Vil-Arch vs. TRPV1-Arch responders (p = 
0.57; Mann-Whitney test). 
3.3.3  Dextran sulfate sodium-mediated inflammation causes visceral hypersensitivity 
To examine the role of epithelial cells in inflammation-induced hypersensitivity, we used 
the dextran sulfate sodium (DSS) model of inflammatory bowel disease. DSS damages the 
mucosal barrier, causing inflammation and other symptoms that mimic human ulcerative colitis 
(Chassaing, Aitken, Malleshappa, & Vijay-Kumar, 2014). After testing dose and time variables, 
we used a protocol in which 3% DSS is administered in the drinking water for 5 days prior to VMR 
analysis, as it consistently produced hypersensitivity. Histopathological comparison of vehicle-
treated (Figure 13A) versus DSS-treated (Figure 13B) colons showed that this DSS protocol did 
not cause notable loss of lining epithelial cells, which allowed further examination of epithelial-
neuronal communication. In addition, fluorescent images of vehicle-treated (Figure 13C) versus 
DSS-treated (Figure 13D) Vil-Arch colons showed that Arch-EGFP expression was not reduced 
by DSS treatment.  
Though the epithelial lining is intact, histopathological analysis (Kim et al., 2012) showed 
that DSS-treated mice had a higher inflammation score, as indicated by fewer mucous-secreting 
goblet cells, more infiltrating immune cells, and thickening of the submucosal layer (n = 10 in 
vehicle-treated group and n = 12 in DSS-treated group; p < 0001, unpaired t-test; Figure 13E). 
Increased spleen weights in DSS-treated mice, an indicator of inflammation, were also present (n 
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= 11 in vehicle-treated group and n = 11 in DSS-treated group; p = 0.007; unpaired t-test with 
Welch’s correction; Figure 13F). These data were pooled from vehicle- and DSS-treated Vil-
Arch, TRPV1-Arch, and control mice, as previous analysis showed that genotype did not have an 
effect on inflammation. When comparing disease scores in DSS-treated Vil-Arch, TRPV1-Arch, 
and control mice, there was a main effect of DSS (p < 0.0001) but not genotype (p = 0.09), and 
there was no interaction between DSS and genotype (p = 0.16; two-way ANOVA). When 
comparing spleen weights, there was a main effect of treatment (p = 0.01) but not genotype (p = 
0.91), and there was no interaction (p = 0.99; two-way ANOVA).  
Previous studies have shown that DSS treatment at various doses can result in visceral 
hypersensitivity (Kalra et al., 2018; Scanzi et al., 2016; Verma-Gandhu et al., 2007). To confirm 
that our DSS protocol produced hypersensitivity, VMR analysis was conducted in Vil-Arch mice. 
Mice were stimulated with CRD pressures of 40, 60, and 80 mmHg. There were main effects of 
DSS treatment (p = 0.02) and distension pressure (p < 0.0001) with a significant interaction (p = 
0.002; two-way ANOVA). In addition, the VMR in response to 60 and 80 mmHg was significantly 
greater in DSS treated than vehicle-treated mice (p = 0.01 and p < 0.001, respectively; Sidak’s test; 
n = 5 mice per group) (Figure 13G). 
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Figure 13. Dextran sulfate sodium (DSS) treatment induces colon inflammation and visceral hypersensitivity 
Dextran sulfate sodium (DSS) treatment induces colon inflammation and visceral hypersensitivity. Mice were 
administered 3% DSS for 5 days or vehicle treatment. Histopathological analysis of vehicle-treated (A) vs. DSS-
treated (B) colons showed that the DSS protocol did not cause a notable loss in lining epithelial cells. There was a 
depletion of goblet cells (indicated by *), increase in infiltrating cells (indicated by **), and thickening of the 
submucosal layer (indicated by ***). Fluorescent images of vehicle-treated (C) and DSS-treated (D) villin-
Archaerhodopsin (Vil-Arch) colons showed comparable enhanced green fluorescent protein (EGFP) expression, 
indicating that Arch-EGFP expression is not ablated after DSS treatment. (E) DSS-treated mice had a higher 
inflammation disease score, indicating fewer mucous-secreting goblet cells, more infiltrating cells, and expansion of 
the submucosa (n = 10 in vehicle-treated group and n = 12 in DSS-treated group; p < 0.0001, unpaired t-test). (F) 
DSS-treated mice also had significantly higher spleen weights indicating inflammation n = 11 in vehicle-treated group 
and n = 11 in DSS-treated group; p = 0.007; unpaired t-test with Welch’s correction. (G) Visceromotor responses 
(VMRs) to colorectal distension (CRD) were measured in vehicle- and DSS-treated mice. Mice received multiple 
CRD pressures (40, 60, and 80 mmHg) and showed significantly greater VMRs at 60 (p = 0.01) and 80 mmHg (p < 
0.001; two-way ANOVA with Sidak’s test; n = 5 mice per group). Scale bars = 100 𝜇M. 
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3.3.4  Inhibition of the colon epithelium reduces DSS-induced hypersensitivity 
As our DSS protocol produced hypersensitivity to CRD in response to 60 mmHg pressure, 
we used this stimulus intensity to assess the impact of light stimulation on the VMR in DSS-treated 
control and Vil-Arch mice. VMRs to CRD were recorded in Vil-Arch and control littermate mice, 
both treated with DSS. Measures were made before (baseline) and during application of light 
stimulation (Figure 14A). Yellow light produced effective inhibition in 4 out of 5 Vil-Arch mice, 
reducing the VMR by 51 ± 9% (baseline VMR to CRD: 2.66 ± 0.57 V*s vs. VMR to CRD + laser: 
1.22 ± 0.41 V*s; Figure 14B). Yellow light was effective in inhibiting the VMR in 60 ± 9% of 
trials (Figure 14B inset). In the 1 Vil-Arch mouse that did not respond to yellow light, the baseline 
VMR to CRD was 2.58 V*s and the average VMR to CRD + laser was 2.49 V*s. In the control 
littermate mice (n = 4), no reduction in VMR in response to light stimulation was observed 
(baseline VMR to CRD: 2.1 ± 0.2 V*s vs. average VMR to CRD + laser: 2.68 ± 0.42 V*s; Figure 
14C). Yellow light induced inhibition in the DSS-treated Vil-Arch mice to a similar extent 
compared to untreated Vil-Arch mice (vehicle: 67 ± 19% inhibition vs. DSS: 51 ± 9%; p = 0.57; 
unpaired t-test; Figure 14D).  
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Figure 14. Inhibition of colon epithelium reduces DSS-induced visceral hypersensitivity 
Inhibition of colon epithelium reduces dextran sulfate sodium (DSS)-induced hypersensitivity. (A) Visceromotor 
responses (VMRs) to 60 mmHg colorectal distension (CRD) were recorded in DSS-treated villin-Archaerhodopsin 
(Vil-Arch) and control littermate mice before (Baseline) and during yellow light stimulation (+ Laser). (B) Yellow 
light produced effective inhibition in 4 out of 5 Vil-Arch mice, in an average of 60% of CRD + laser trials (inset). (C) 
In control littermate mice (n = 4), no reduction in VMR in response to light stimulation was observed. (D) Yellow 
light-induced inhibition in DSS-treated Vil-Arch mice was similar to inhibition in untreated Vil-Arch mice (n = 4 per 
group; p = 0.57; unpaired t-test). 
3.3.5  Inhibition of colon ExPANs reduces DSS-induced hypersensitivity 
I next examined the effects of inhibiting colon afferents on DSS-induced hypersensitivity. 
VMRs to CRD were recorded in TRPV1-Arch and control littermate mice before (baseline) and 
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during yellow light stimulation (Figure 15A). Yellow light was effective in inhibiting the VMR 
to CRD in 5 out of 6 TRPV1-Arch mice. In the CRD trials that were inhibited, yellow light reduced 
the VMR by 62 ± 8% (baseline VMR to CRD: 2.17 ± 0.39 V*s vs. VMR to CRD + laser: 1.82 ± 
0.31 V*s; Figure 15B). Inhibition occurred in an average of 54% of the CRD + laser trials in these 
mice (Figure 15B inset). In the 1 TRPV1-Arch mouse that did not respond to yellow light, the 
baseline VMR to CRD was 2.07 V*s and the average VMR to CRD + laser was 2.09 V*s. In 
control littermate mice (n = 4), yellow light-induced reduction in VMR only occurred in 1 CRD + 
laser trial in 1 mouse. In all other trials, this reduction was not observed (baseline VMR to CRD: 
1.93 ± 0.45 V*s vs. average VMR to CRD + laser: 2.07 ± 0.39 V*s; Figure 15C). Yellow light 
induced inhibition in the DSS-treated TRPV1-Arch was compared to inhibition in untreated 
TRPV1-Arch mice (vehicle: 83 ± 8% inhibition vs. DSS: 53 ± 11%; p = 0.11; Mann-Whitney test; 
Figure 15D). There was a trend towards a decrease in the extent of inhibition in DSS-treated mice, 
but this was not significant. Finally, comparison between inhibition via Arch-expression in the 
epithelium versus inhibition in colon afferents showed that both were similarly effective at 
reducing the VMR response in inflamed mice. No statistical differences were detected in the extent 
of inhibition in responding trials [main effect of yellow light (p = 0.001), no effect of genotype (p 
= 0.57), 2-way ANOVA; Figure 15E] or in the rate of inhibited trials (p = 0.62, Mann-Whitney; 
Figure 15F). 
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Figure 15. Inhibition of colon ExPANs reduces DSS-induced visceral hypersensitivity 
(A) Visceromotor responses (VMRs) to colorectal distension (CRD) were recorded in DSS-treated transient receptor 
potential vanilloid 1 (TRPV1)-Archaerhodopsin (Arch) and control littermate mice before (Baseline) and during 
yellow light stimulation (+ Laser). (B) Yellow light produced effective inhibition in 5 out of 6 TRPV1-Arch mice, in 
an average of 45% of CRD + laser trials (inset). (C) In the control littermate mice (n = 4), no reduction in VMR in 
response to light stimulation was observed. (D) Yellow light-induced inhibition in the DSS-treated TRPV1-Arch 
mice (n = 5) was compared to inhibition in untreated TRPV1-Arch mice (n = 4). There was a trend for a decrease in 
inhibition in DSS-treated mice, but this was not significant (p = 0.11; Mann-Whitney test). (E) Comparing DSS-
treated Vil-Arch (n = 4) and TRPV1-Arch (n = 5) mice that responded to yellow light shows no statistical 
differences in the extent of inhibition in responding trials [main effect of yellow light (p = 0.001), no effect of 
genotype (p = 0.57); 2-way ANOVA]. (F) There was also no significant difference in the percentage of inhibited 
trials in Vil-Arch vs. TRPV1-Arch responders (p = 0.62; Mann-Whitney test).  
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3.4 Discussion 
Results from this study show that Arch-mediated inhibition of colon epithelial cells 
diminishes visceral nociceptive responses in both healthy mice and mice with DSS-induced 
inflammation. In Vil-Arch animals that displayed yellow light-induced decreases in VMR, 
inhibiting the epithelium reduced VMRs by more than 80%. Notably, epithelial inhibition was 
similarly effective as colon afferent inhibition in reducing the VMR. When combined with our 
previous findings that ChR2-mediated excitation of the colon epithelium evokes VMRs (Makadia 
et al., 2018), these results support the role of the epithelium as a critical component of nociceptive 
signaling.  
How changes in the epithelium specifically impact the response to noxious stimuli has 
proven difficult to study because of the complexity of neural and epithelial cell types and the 
intimate association of nerve terminals and the epithelium, e.g., chemical or mechanical 
stimulation of the colon simultaneously activates both nerves and epithelial cells, making the 
relative contribution of each cell type undecipherable. To overcome this limitation, we used villin-
Cre driver mice to genetically target the inhibitory Arch opsin to all epithelial cells lining the colon. 
This allowed a specific assessment of the contribution of the epithelium to distension evoked 
VMRs and revealed that inhibition of the epithelium reduces visceral hypersensitivity. However, 
because the villin-Cre driver targets enterocyte, goblet, enterochromaffin and enteroendocrine cell 
subpopulations it is not possible to determine which of these subpopulations of epithelial cell types 
mediates the effects of light stimulation. Thus, future studies will employ additional Cre-lines will 
reveal the contribution of different epithelial cell types to visceral nociception. 
Although VMR is a reliable way to assess visceral sensitivity (Christianson & Gebhart, 
2007), we observed variability in responses to CRD within the Vil-Arch and TRPV1-Arch groups. 
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Some Arch-expressing mice did not display yellow light mediated inhibition of the VMR in any 
CRD + laser trials. This variability in VMR is likely due to inappropriate positioning of the laser 
or excessive luminal contents that occluded the laser. The lack of a reliable response could also be 
due to the interstimulus interval used in these experiments. We consistently waited 4 min in 
between distension and distention + laser trials, and this may not have been enough time for the 
Arch proton pump to reset properly. Variability could also be attributed to the possibilities that 
different epithelial cell types play different roles in the regulation of ExPAN activity, or Arch 
activation has different effects in subpopulations of epithelial cells. That is, while previous studies 
showed light activation of Arch leads to proton release and membrane hyperpolarization, 
preventing action potential firing in neurons (Chow et al., 2010), it remains to be determined how 
Arch-mediated hyperpolarization of colon epithelial cell membranes results in the ‘silencing’ of 
epithelial cells and inhibition of distension-induced VMRs. One possibility is that 
hyperpolarization blocks the distension (stretch)-mediated release of ATP from the epithelium, 
which is known to activate purinergic receptors expressed on extrinsic afferent terminals 
(Burnstock, 2001; Makadia et al., 2018). Release of 5-HT from the subset of electrically excitable 
enterochromaffin cells, as shown in cultured organoids (Alcaino et al., 2018; Bellono et al., 2017) 
may also be changed by Arch-mediated hyperpolarization.  
Our studies indicate limitations in the extent to which inhibition of colon epithelial cells or 
ExPANs can reduce VMRs to CRD. Post DSS treatment, both epithelial and ExPAN inhibition 
were effective in reducing hypersensitivity. However, averaging of VMR values showed that 
neither could by itself completely reverse the hypersensitivity, i.e., blocking peripheral 
components of the VMR could not normalize sensitivity to CRD after inflammation. The inability 
to completely reverse hypersensitivity suggests that Arch-mediated inhibition did not sufficiently 
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inhibit colon afferents. There could also be a role for central sensitization in this inflammatory 
state. Future studies will investigate how other components involved in the VMR circuit contribute 
to visceral hypersensitivity. 
Visceral pain is notoriously difficult to treat, often persisting long after the precipitating 
injury or disease is no longer evident. Chronic disruptive changes in the epithelial lining may affect 
normal epithelial-neural signaling leading to persistence in hypersensitivity. Indeed, changes were 
identified in muscarinic signaling in urothelial cells isolated from the bladder of patients with 
chronic interstitial cystitis (Gupta, Lu, Gold, & Chai, 2009), suggesting injury can evoke long-
term changes in epithelial signaling properties. It remains to be determined whether there are 
similar long-term changes in colon epithelial cells, though there is some research that shows 
inflammation can affect the abundance and neurotransmitter content of enteroendocrine cells 
(Lomax et al., 2006). These changes with inflammation should be further studied, as the work here 
confirms that the epithelium is a powerful component in nociceptive signaling, suggesting that it 
is a potential target for treatment of visceral pain.  
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4.0 Optogenetic Activation of the Colon Epithelium Engages Enteric Nervous System 
Circuits to Initiate Colon Motility 
4.1 Introduction 
The enteric nervous system (ENS) is a network of neural ganglia intrinsic to the 
gastrointestinal (GI) tract that controls motility, local blood flow, mucosal transport and secretion. 
Dysregulation of motility patterns are associated with constipation and diarrhea and can result in 
a significant reduction in quality of life. Dysregulation of gut motility is also now recognized as a 
symptom of diseases previously thought to only affect the brain, e.g., autism, diabetes and 
Parkinson’s (Bessac, Cani, Meunier, Dietrich, & Knauf, 2018; Chalazonitis & Rao, 2018; Dinan 
& Cryan, 2017). Colon motility is dependent on controlled sensory-motor reflexes in the ENS, in 
which neurons responsive to mechanical or chemical changes in the intestinal lumen generate 
propulsive contractions. Most ENS neurons associated with motor function are located in the 
myenteric plexus whereas the neurons that initiate these reflexes are intrinsic primary afferent 
neurons (IPANs) (Costa et al., 2000).  
IPANs are specialized sensory neurons unique to the GI tract that respond to mechanical 
and chemical stimuli in the lumen (Furness, Jones, Nurgali, & Clerc, 2004). In mouse colon, 
IPANs that originate in the myenteric plexus have processes that can extend into the mucosal layer 
and terminate in close apposition to colon epithelial cells (Furness, Robbins, et al., 2004). IPANs 
detect mechanical stimuli and initiate enteric reflexes (Bertrand et al., 1998), but how this signaling 
occurs and the role of the epithelium in this process is not clear. A role for colon epithelial cells as 
an intermediary between luminal stimuli and enteric neuron activation is supported by the 
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anatomical localization of terminals and by numerous studies of epithelial cells, enteroendocrine 
cells (EECs) in particular, that show expression of neuroactive compounds and their receptors 
(Najjar et al., 2020). Receptors expression would allow the epithelium to directly detect and 
respond to changes in luminal stimuli, perhaps through release of neurotransmitters such as ATP 
(Burnstock, 2014; Makadia et al., 2018) and serotonin (5-HT) (Gershon, 2013). Enterochromaffin 
cells, a type of EEC, are the main source of 5-HT in the body. These cells express receptors for 
chemical irritants (transient receptor potential ankyrin 1) (Nozawa et al., 2009) and mechanical 
stimulation (Piezo2) (Alcaino et al., 2018). In response to activation of these receptors, 
enterochromaffin cells release 5-HT, which binds 5HT receptors on local neuron terminals and is 
so doing, activate circuits controlling motility (Grider et al., 1996; Kadowaki et al., 1996; Nozawa 
et al., 2009).  
The extent to which colon epithelial cells regulate ENS circuits is a major unanswered 
question. It is debated whether the epithelium has a role in colon motility, particularly for colonic 
migrating motor complexes (CMMCs), which are rhythmic motor patterns that facilitate the 
movement of fecal matter through the colon (Spencer, 2001). Evidence supports a role for mucosal 
5-HT as essential for normal propagation of motor patterns in the colon (Heredia et al., 2009; 
Heredia et al., 2013; Smith & Gershon, 2015). Other studies contend that signaling from the 
mucosa is not required for generation of motor patterns, and rather that mucosal-derived serotonin 
has a modulatory role (Keating & Spencer, 2010; Spencer et al., 2015). Given these discrepancies, 
the aim of this study was to investigate the role of the epithelium in motility by assessment of ENS 
neuron activity and colon motility in response to direct epithelial activation.  
To enable specific activation of the epithelium we used an ex vivo colon preparation of the 
mouse in which the blue light activated excitatory channelrhodopsin protein (ChR2) is expressed 
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in colon epithelial cells. Simultaneous with epithelial cell activation, we measured changes in 
calcium (Ca2+) in neurons of the myenteric plexus using a red-shifted genetically encoded Ca2+ 
indicator (GECIs) and measured local colon motility and CMMCs. Our studies show that light 
stimulation of the epithelium caused activation of a subpopulation of myenteric neurons that led 
to local motility changes in the distal colon and increased the rate of CMMCs. Antagonism of ATP 
signaling, but not of 5-HT, caused reduction in epithelial-evoked changes in motility. Overall, our 
findings indicate that colon epithelial cells induce neuronally-mediated changes in motility through 
purinergic signaling.  
4.2 Methods 
4.2.1  Animals 
Adult male and female mice 2-12 months old were used. As described previously (Makadia 
et al., 2018), channelrhodopsin (ChR2) was targeted to the intestinal epithelium under control of 
the villin-Cre driver. Mice with a ChR2-EYFP fusion protein [ChR2(H134R)-EYFP] in the 
Rosa26 locus downstream of a floxed-STOP cassette (Ai32 mice; RRID: IMSR_JAX:012659) 
were crossed with villin-Cre mice (RRID: IMSR_JAX004586). Littermates with ChR2-EYFP but 
lacking Cre were used as controls. Animals were housed in an AAALAC-approved facility and 
handled in accordance with protocols approved by the University of Pittsburgh Institutional 
Animal Care and Use Committee. 
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4.2.2  RCaMP/R-GECO expression in enteric neurons 
P2-P4 neonatal mice were injected intraperitoneally with RCaMP or R-GECO virus to 
enable expression throughout the peripheral nervous system. Insulin syringes (3/10 cc, 31 G; 
Allison Medical, Littleton, CO) were used to inject 10 µL of RCaMP virus 
(pAAV.Syn.NES.jRCaMP1b.WPRE.SV40, Addgene, Watertown, MA) or R-GECO virus 
(AAV9.Syn.NES-jRGECO1a.WPRE.SV40; Addgene). Mice were analyzed at least 6 weeks after 
injection. 
4.2.3  Imaging Ca2+ transients and local motility 
After euthanasia with isoflurane, distal colons were isolated and placed in a Sylgard-lined 
dish containing artificial cerebrospinal fluid (ACSF), containing (in mM): 117.9 NaCl, 4.7 KCl, 
25 NaHCO3, 1.3 NaH2PO4, 1.2 MgSO4-7H2O, 2.5 CaCl2, 11.1 D-glucose, 2 sodium butyrate, and 
20 sodium acetate. Fecal contents were flushed from the lumen and the colon was opened 
longitudinally and pinned flat with serosal side up. During imaging, the dish was superfused with 
ACSF and maintained at 35º C. Nifedipine (4 µM, Sigma-Aldrich) was added to the ACSF to 
prevent spontaneous colon movement. The myenteric plexus was visualized at 40x using an 
upright Leica DM6000FS fluorescent microscope (Leica, Buffalo Grove, IL). Activity in 
myenteric neurons and movements of the colon were recorded using a CMOS camera (Prime 95B 
Photometrics; Roper Scientific, Tucson, AZ) at a 20 Hz sampling rate, 50 ms exposure time. Image 
stacks were collected in Metamorph software (Molecular Devices, San Jose, CA). Activity was 
recorded before, during, and after blue light stimulation. Stimulation was delivered using a 473 
nm wavelength laser (Laserglow Technologies, Toronto, Canada) with a 1.5 mm optical fiber 
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(ThorLabs, Newton, NJ). The optical fiber was positioned 2-3 mm away from the imaging field, 
in the aboral direction, and 3 mm above the colon, enabling the optical fiber to deliver 20 mW of 
laser power to the colon tissue. Light stimulation was delivered for 20 s (Makadia et al., 2018).  
4.2.4  Drugs used 
Tetrodotoxin (TTX) 0.5 µM and hexamethonium (HEX) 300 µM (both from Sigma-
Aldrich, St. Louis, MO) were dissolved in oxygenated ACSF on the day of the experiment. Drug 
concentrations were chosen based on previous studies (Hibberd, Travis, et al., 2018; Smith-
Edwards et al., 2019). The ATP receptor antagonist cocktail consisted of the following drugs (all 
from Tocris Bioscience, Minneapolis, MN): TNP-ATP triethylammonium salt (P2X1, P2X2/3, and 
P2X3 antagonist, dissolved in H2O for a 100 µM stock solution), 5-BDBD [P2X4 antagonist, 
dissolved in dimethylsulfoxide (DMSO, Sigma-Aldrich) for a 30 mM stock solution], MRS 2500 
(P2Y1 antagonist, dissolved in H2O for a 1 mM stock solution), AR-C 118925XX (P2Y2 
antagonist, dissolved in DMSO for a 5 mM stock solution), and MRS 2578 (P2Y6 antagonist, 
dissolved in DMSO for a 5 mM stock solution). Drugs were added to ACSF for final 
concentrations of 20 nM TNP-ATP, 20 µM 5-BDBD, 10 µM MRS 2500, 10 µM AR-C118925XX, 
and 1 µM MRS 2578. The 5-HT receptor antagonist cocktail consisted of the following drugs: 
alosetron (Sigma-Aldrich, 5-HT3 antagonist, dissolved in H2O for a 20 mM stock solution), 
ketanserin (Tocris, 5-HT2 antagonist, dissolved in H2O for a 1 mM stock solution), and GR 113808 
(Tocris, 5-HT4 antagonist, dissolved in HCl for a 20 mM stock solution). Drugs were added to 
ACSF for final concentrations of 20 µM alosetron, 2 µM ketanserin, and 2 µM GR 113808. Colon 
tissue was imaged after 15 min of antagonist drug incubation.  
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4.2.5  Whole colon motility 
After euthanasia with isoflurane, entire colons were isolated and placed in a Sylgard-lined 
dish containing ACSF. After fecal contents were flushed, the colon was gently pinned at the 
mesentery to the dish. The dish was superfused with ACSF and maintained at 35º C. Measures of 
motility began as soon as spontaneous colonic migrating motor complexes (CMMCs) were 
observed (about 10-30 min after dissection from the mouse). Spontaneous contractions were video 
recorded (Sony, HDR-CX440) for 20 min. In some experiments, colons were connected to a force 
transducer to measure changes in tension (mN) during CMMC propagation. To test the effects of 
blue light stimulation on CMMCs, a fiber optic was secured directly above the colon at 1 cm from 
the anus (location determined from local motility studies). Pulsed blue laser stimulation on the 
colon was done for 20 s every 2 min, for 20 min total, while CMMCs were video recorded. Video 
analysis done blinded to the mouse genotype counted the number of CMMCs observed over the 
course of the 20-min videos. CMMCs were defined as circular contractions initiated in the 
proximal colon that propagated at least 1 cm; only anterograde CMMCs (i.e., those traveling in 
the oral to aboral direction) were included for analysis. 
4.2.6  Data analysis 
Analyses of imaging files and video recordings of colon motility were conducted in a 
blinded manner. Images collected in Metamorph were exported to ImageJ (National Institutes of 
Health, Bethesda, MD). Local motility, i.e., colon tissue movement, was quantified using the 
Template Matching plugin in ImageJ as previously described (Smith-Edwards et al., 2019). The 
amplitudes of calcium indicator signals were quantified by calculating ∆F/F0 as % = [(F – F0/F0)] 
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x 100, where F is the peak fluorescence signal and F0 is the baseline fluorescence signal. Statistical 
analyses were performed in Prism (GraphPad, San Diego, CA) and included unpaired Student’s t-
test, one-way and two-way analysis of variance (ANOVA) with post-hoc tests as indicated in 
results. Data is represented as mean ± standard error of the mean and results were considered 
significant when p ≤ 0.05. 
4.3 Results 
4.3.1  Optogenetic stimulation of colon epithelium changes activity in myenteric neurons 
To determine whether stimulation of colon epithelium affects myenteric neuron activity, 
we virally injected red calcium indicators (RGECO, RCaMP) into Vil-ChR2 mice (n=5). This 
strategy allowed for an all-optical approach to investigate intercellular communication in the colon 
(Figure 16A). Myenteric neuron activity was recorded before, during, and after laser stimulation 
(20 s) of the epithelium (Figure 16B). Tracking of activity changes in individual neurons revealed 
a small population of myenteric neurons in the distal colon that were activated by laser stimulation. 
Activated myenteric neurons initially displayed no activity and only began to exhibit calcium 
signals after optogenetic stimulation of the epithelium. Fewer neurons per ganglion responded to 
laser compared to electrical stimulation applied to the same location (Electrical: 14.71 ± 1.43% vs. 
Laser: 6.7 ± 0.89%; p = 0.008; Mann-Whitney test; Figure 16C) indicating that a smaller 
subpopulation of myenteric neurons receives epithelial input. The average amplitude of response 
was not significantly different between laser and electrical stimulation (Electrical: 9.67 ± 1.65 ∆F 
vs. Laser: 8.16 ± 1.61 ∆F; p = 0.53; unpaired t-test; Figure 16D), suggesting the strength of 
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activation in neurons due to laser stimulation was comparable to when neural circuits were directly 
activated. As would be expected in a multi-cell circuit, the latency of response to laser was 
significantly longer than electrical stimulation (Electrical: 0.13 ± 0.02 s vs. Laser: 6.51 ± 0.4; 
p<0.0001, unpaired t-test; Figure 16E). Latencies ranged from 2 – 16 s with the majority of 
responses within 4 s from the start of laser stimulation (Figure 16F).  
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Figure 16. Optogenetic stimulation of colon epithelium initiates activity in myenteric neurons 
(A) Experimental setup: RCaMP/R-GECO was virally expressed in myenteric neurons in Villin-ChR2 mice. Laser 
and electrical stimulation were applied 3 mm below the imaging field. (B) Myenteric neuron activity was recorded 
before, during, and after laser stimulation (20 s) of the epithelium. (C) Electrical stimulation in Vil-ChR2 mice (n = 
5), initiated Ca2+ transients in a greater percentage of myenteric neurons than laser stimulation (p = 0.008; Mann-
Whitney test). (D) The average amplitude of response observed in myenteric neurons was not significantly different 
between laser and electrical stimulation (p = 0.53; unpaired t-test). (E) The latency of response to laser was 
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significantly longer than electrical stimulation (p < 0.0001, unpaired t-test). (F) Latencies ranged from 2-16 s with the 
majority of responses within 4 s from the start of laser stimulation. 
4.3.2  Optogenetic stimulation of colon epithelium initiates changes in local motility 
Epithelial activation also evoked movement patterns in the imaging field, characterized by 
tissue movement in the longitudinal and circular directions (Figure 17A). Movement patterns were 
observed in fields throughout the distal colon, 0.8 – 2.8 cm from the anus (Figure 17A inset). 
Example traces illustrate the epithelium-evoked movement in Vil-ChR2 mice (n = 7) compared to 
the minimal movement in colons of control mice (n = 4; Figure 17B). On average, the colon was 
displaced 81.15 ± 15.68 µm in the longitudinal direction (compared to 2.88 ± 1.12 µm in control 
animals; p = 0.006; Mann-Whitney test; Figure 17C) and 38.17 ± 12.43 µm in the circular 
direction (compared to 0.38 ± 0.30 µm in control animals; p = 0.006; Mann-Whitney test; Figure 
17D). As seen for myenteric neuron activation (Figure 16E), there was a latency between the start 
of blue light stimulation and colon movement which was significantly longer than the latency to 
movement with electrical stimulation (Electrical: 1.04 ± 0.18 s vs. Laser: 7.83 ± 1.04 s; p = 0.0005; 
Mann-Whitney test; Figure 17E). Latencies ranged from 2 – 40 s, with the majority of responses 
occurring within 6 s from the onset of laser (Figure 17F). 
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Figure 17. Optogenetic stimulation of colon epithelium initiates changes in local motility 
(A) Epithelial activation evoked movement patterns in the imaging field, characterized by tissue movement in the 
longitudinal and circular directions, observed in fields throughout the distal colon (inset). (B) Example traces illustrate 
the epithelium-evoked movement in Vil-ChR2 mice (n = 7) compared to the minimal movement in colons of control 
mice (n = 4). (C) In the longitudinal direction, laser-evoked movement was significantly greater in Vil-ChR2 mice 
compared to controls (p = 0.0006; Mann-Whitney test). (D) Laser-evoked movement in the circular direction was also 
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greater in Vil-ChR2 mice (p = 0.006; Mann-Whitney test). (E) There was a latency between the start of blue light 
stimulation and colon movement which was significantly longer than the latency with electrical stimulation (p = 
0.0005; Mann-Whitney test). (F) Latencies ranged from 2 – 40 s, with the majority of responses occurring within 6 s 
from the onset of laser. 
 
4.3.3  Epithelium-induced motility is mediated by neuronal activity 
We hypothesized that the epithelium, upon activation, signals to enteric neurons to produce 
the observed movement patterns. Acetylcholine (ACh) is the major neurotransmitter for synaptic 
transmission in the ENS and is released from enteric motor neurons to produce smooth muscle 
contractions (Sang & Young, 1998). Therefore, the nicotinic ACh receptor antagonist 
hexamethonium (HEX, 300 µM) was added to the bath to test whether laser-induced movement 
was reduced by blocking synaptic transmission in enteric neural circuits. We also used tetrodotoxin 
(TTX, 0.5 µM), a voltage gated Na+ channel blocker, to confirm that laser-induced movement 
depended on action potential firing in neurons. As shown in the example traces, epithelial-evoked 
movement of the colon (Figure 18A) was effectively reduced in the presence of HEX (Figure 
18B) and TTX (Figure 18C). There was a significant decrease in colon movement when either 
HEX or TTX was applied (vehicle: 79.76 ± 18.31 µm vs. HEX: 14.89 ± 7.14 µm; p = 0.03 and 
TTX: 12.17 ± 3.88 µm; p = 0.02; one-way ANOVA; Figure 18D), confirming that blue light-
evoked colon movement observed in Vil-ChR2 mice is neuronally-mediated. 
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Figure 18. Epithelium-induced motility is neuronally mediated 
Epithelial-evoked movement of the colon (A) was effectively reduced by the presence of HEX (B) and TTX (C). (D) 
There was a significant decrease in colon movement when either HEX or TTX was applied (n = 4; HEX: p = 0.03 and 
TTX: p = 0.02; one-way ANOVA), confirming that blue light-evoked colon movement observed in Vil-ChR2 mice is 
neuronally-mediated. 
4.3.4  ATP mediates epithelium-ENS interactions 
Pharmacological approaches were applied to begin to define the mechanism by which the 
epithelium initiates colon motility. Two candidate neurotransmitters were tested: 5-HT and ATP, 
both important signaling molecules in the ENS. A cocktail of 5-HT receptor antagonists (alosetron, 
ketanserin, and GR113808) was applied to the bath and local motility was assessed. Tissue 
movement evoked by blue light and spontaneous colon movement in the presence of the 
antagonists were recorded. The total spontaneous movement (combined x- and y-directions) did 
not change with the addition of 5-HT receptor antagonists (vehicle: 13.95 ± 3.95 µm vs. 5-HT 
receptor antagonists: 14.04 ± 5 µm; p = 0.99; paired t-test; Figure 19A). Example traces show 
 92 
similar spontaneous movement in the presence of vehicle (Figure 19Bi) and 5-HT receptor 
antagonists (Figure 19Bii). Surprisingly, the blue light-evoked movement also did not change after 
the addition of 5-HT receptor antagonists (vehicle: 23.4 ± 5.41 µm vs. 19.57 ± 2.77 µm; p = 0.48; 
paired t-test; Figure 19C). Example traces show similar evoked movement in the presence of 
vehicle (Figure 19Di) and 5-HT receptor antagonists (Figure 19Dii). However, the ATP receptor 
antagonist cocktail (TNP-ATP, 5-BDBD, MRS 2500, AR-C118925XX, and MRS 2578) did 
reduce local motility. Spontaneous movement significantly decreased after addition of ATP 
receptor antagonists (vehicle: 24.81 ± 3.73 µm vs. ATP receptor antagonists: 11.87 ± 0.75 µm; p 
= 0.05; paired t-test; Figure 19E). Example traces show spontaneous movement with vehicle 
treatment (Figure 19Fi) that is decreased in the presence of ATP receptor antagonists (Figure 
19Fii). Evoked movement was also significantly reduced (vehicle: 42.37 ± 10.48 µm vs. ATP 
receptor antagonists: 7.53 ± 1.86 µm; p = 0.03; paired t-test; Figure 19G). Example traces show 
evoked movement with vehicle treatment (Figure 19Hi) that is decreased in the presence of ATP 
receptor antagonists (Figure 19Hii). 
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Figure 19. ATP mediates epithelium-ENS interactions 
(A) Total spontaneous movement (combined x- and y-directions) did not change with the addition of 5-HT receptor 
antagonists (n = 4; p = 0.99; paired t-test). Example traces show similar spontaneous movement in the presence of 
vehicle (Bi) and 5-HT receptor antagonists (Bii). (C) The blue light-evoked movement also did not change after the 
addition of 5-HT receptor antagonists (p = 0.48; paired t-test). Example traces show similar evoked movement in the 
presence of vehicle (Di) and 5-HT receptor antagonists (Dii). (E) Spontaneous movement significantly decreased after 
addition of ATP receptor antagonists (p = 0.05; paired t-test). Example traces show spontaneous movement with 
vehicle treatment (Fi) that is decreased in the presence of ATP receptor antagonists (Fii). (G) Evoked movement was 
also significantly reduced with ATP receptor antagonists (p = 0.03; paired t-test). Example traces show evoked 
movement with vehicle treatment (Hi) that is decreased in the presence of ATP receptor antagonists (Hii). 
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4.3.5  Optogenetic activation of the epithelium facilitates colonic migrating motor 
complexes (CMMC) 
Given the impact of epithelial activation on local motility in the colon, we next tested 
whether activation of the epithelium could influence whole-colon motility patterns. Colonic 
migrating motor complexes (CMMCs) are rhythmic propulsive contractions mediated by enteric 
neurons that normally occur every 3-5 min. Video recordings captured CMMCs at spontaneous 
baseline levels and with the application of blue laser to the whole colon, 1 cm from the anus 
(Figure 20A). Laser stimulation occurred every 2 min for 20 s and changes in CMMC rate were 
quantified in Vil-ChR2 (n = 10) and control littermate mice (n = 10). There was a significant 
interaction between genotype and laser in these experiments (p = 0.02; two-way ANOVA). Post-
hoc analysis revealed that blue light activation of the epithelium increased the rate of CMMCs in 
Vil-ChR2 mice (baseline CMMC rate: 0.22 ± 0.02 per min vs. CMMC rate with laser: 0.32 ± 0.03 
per min; p = 0.001; Sidak’s test; Figure 20B). The rate of CMMCs in the control mice did not 
change (baseline CMMC rate: 0.25 ± 0.02 per min vs. CMMC rate with laser: 0.26 ± 0.02 per min; 
p = 0.88; Sidak’s test).  
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Figure 20. Optogenetic activation of the epithelium facilitates CMMCs 
(A) Video recordings captured CMMCs at spontaneous baseline levels and with the application of blue laser to the 
whole colon, 1 cm from the anus. Changes in CMMC rate were quantified in Vil-ChR2 (n = 10) and control littermate 
mice (n = 10). (B) There was a significant interaction between genotype and laser in these experiments (p = 0.02; two-
way ANOVA). Blue light activation of the epithelium increased the rate of CMMCs in Vil-ChR2 mice (p = 0.001; 
Sidak’s test). The rate of CMMCs in the control mice did not change (p = 0.88; Sidak’s test). 
4.4 Discussion 
The goal of this study was to investigate the role of the epithelium in colon motility. We 
employed optogenetic stimulation of epithelial cells coupled with optical measurement of neuronal 
activity, establishing this study as the first to interrogate ENS circuits using all optical techniques. 
The ability to selectively activate epithelial cells and measure activity in the colon allowed an 
examination of how the epithelium communicates with myenteric neurons to influence colon 
motility. Given that epithelial cells can release neurotransmitters, we predicted that optogenetic 
activation of colon epithelial cells would evoke measurable responses in myenteric neurons. 
Results indicate that epithelial activation initiated Ca2+ activity in myenteric neurons in the distal 
colon and produced a functional outcome, evidenced by local colon motility. Our studies also 
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suggest that ATP, and possibly 5-HT, underlie this local epithelial-evoked movement. In full-
length, closed colon preparations, epithelial activation in the distal colon increased the rate of 
CMMCs initiated in the proximal colon, indicating that the colon epithelium has potential to 
influence large-scale coordination of ENS activity.  
Studies have suggested that colon epithelial cells have reciprocal interactions with 
myenteric neurons (Walsh & Zemper, 2019). However, it has been a challenge to record activity 
from myenteric neurons and simultaneously activate the epithelium. For example, 
electrophysiological recording in the myenteric plexus in situ requires removal of the epithelium 
and submucosal layer (Bertrand, 2003). Recent studies have taken advantage of genetically 
encoded calcium indicators (GECI) to measure neuronal activity in the ENS in intact preparations 
(Hennig et al., 2015; Koussoulas, Swaminathan, Fung, Bornstein, & Foong, 2018; Li et al., 2019; 
Swaminathan, Hill-Yardin, Bornstein, & Foong, 2019). Although GECIs do not provide the same 
single-spike resolution as intracellular recordings, they act as a proxy for neuronal activity that 
enables monitoring of activity in peripheral neurons in situ (Akerboom et al., 2013; T. W. Chen et 
al., 2013; Smith-Edwards, DeBerry, Saloman, Davis, & Woodbury, 2016; Tian, Hires, & Looger, 
2012). Green fluorescent GECIs, such as GCaMP, are more commonly used to measure neuronal 
activity but could not be used in this study because the blue excitation light for these GECIs also 
activates ChR2. Red-shifted GECIs require a green excitation light, enabling us to image the 
myenteric plexus while using blue light to activate ChR2-expressing epithelial cells. 
Unfortunately, red-shifted GECIs, including jRCaMP1b and jRGECO1a used here, are not as 
sensitive to Ca2+ compared to GCaMP6s (Dana et al., 2016), but are sufficient to report 
spontaneous activity and evoked responses in many myenteric neurons, albeit at lower numbers 
(Smith-Edwards et al., 2019). Therefore, it is likely that the neural activation observed in response 
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to laser stimulation of the epithelium is an underrepresentation. Future studies should determine 
whether the combination of red-shifted ChR2 and GCaMP6s (the reverse of what was used here) 
is more useful for investigating intercellular connectivity.  
Our imaging parameters enabled measurement of neural activity in addition to localized 
colon tissue movement, which we found was reliably evoked with blue light stimulation of the 
epithelium. As previous studies have shown, these motility changes are likely a result of epithelial 
cells signaling to IPANs that have nerve terminals in the mucosa and cell bodies in the myenteric 
plexus (Costa et al., 2000) and form synaptic connections with interneurons and motor neurons 
(Smolilo et al., 2020). Compared to direct electrical stimulation of ENS circuits, the latency of 
neural activation and movement evoked by laser stimulation was longer. This longer latency is 
likely explained by the release of neuroactive chemicals from the epithelium which then have to 
reach IPAN nerve terminals before engaging the sensory-motor reflex. This compares to our 
previous studies where ChR2-mediated activation of the colon epithelium initiated action potential 
(AP) firing in extrinsic primary afferent neurons (ExPANs). The latency between epithelial 
stimulation and AP firing (mean 15 s) was significantly longer than the latency to AP firing when 
the ExPANs were directly activated (mean 0.34 s) (Chapter 1). 
We sought to determine the neuroactive chemicals mediating epithelial-myenteric neuron 
communication. Previous studies have suggested that 5-HT released by enterochromaffin (EC) 
cells in the colon has a critical role in peristalsis and generation of CMMCs (Heredia et al., 2009; 
Heredia et al., 2013; Jin, Foxx-Orenstein, & Grider, 1999). Other studies indicate that epithelial-
released ATP acts on IPANs in the colon (Bertrand, 2003; Bertrand & Bornstein, 2002; Burnstock, 
2014). We used antagonist cocktails for both 5-HT and ATP, blocking the receptors for these 
neurotransmitters present on enteric neurons. Blocking ATP receptors almost completely 
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abolished the local epithelial-evoked colon movement and while blocking 5-HT receptors also 
reduced the evoked movement, there was only a trend toward significance. This result was 
surprising, given that studies have long suggested that release of 5-HT from the mucosa initates 
sensory-motor reflexes in the colon to produce motility (Grider et al., 1996). However, the laser-
evoked movement was not robust to begin with in experiments using 5-HT receptor blockers, 
possibly explaining the lack of significant effect. It is also possible that addition of the 5-HT 
antagonists to the bath prevented epithelial-evoked colon motility patterns that were not captured 
in our imaging studies, which only recorded local movements in a 30 s timeframe. The release of 
5-HT may be more important in regulating CMMCs, which occur on the order of minutes, than in 
mediating these localized movements occurring only seconds after epithelial stimulation.  
The ability of ATP antagonists to block the fast, local contractions suggests that ATP has 
more rapid effects in activating IPAN nerve terminals. Studies have shown that IPANs display low 
levels of activity even in the absence of applied stimuli and these activity levels are diminished 
without the mucosa intact (Kunze, Bertrand, Furness, & Bornstein, 1997). This observation 
combined with the present study suggests that there is ongoing purinergic signaling from the 
epithelium to surrounding IPANs, which may contribute to spontaneous movements of the colon. 
A major caveat to these interpretations is that ATP signaling also occurs between ENS neurons in 
descending pathways (Burnstock, 2014) and in neuron-glia communication (Gulbransen & 
Sharkey, 2009), so the use of these antagonists may have blocked colon motility independent of 
epithelial signaling.  
This study demonstrates the potential for using optical techniques to interrogate 
intercellular communication between neuronal and non-neuronal cell types in the colon. 
Optogenetic activation of colon epithelial cells revealed their role in ENS neuron activation and 
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colon motility, but we were not able to parse out the effects of different epithelial cell types in this 
study, as ChR2 is ubiquitously expression in the intestinal epithelium under the villin promoter. 
Future studies will target specific activation to enterochromaffin cells as well as other 
subpopulations of EECs, as the neurotransmitters released from these cells may have the most 
direct input to surrounding neurons. Other non-neuronal cell types that are involved in ENS 
function include enteric glia, immune cells, and interstitial cells of Cajal (Furness, 2012). Optical 
techniques can be employed to better understand how these different cell types work together to 
maintain colon health and homeostasis. 
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5.0 Discussion 
The experiments in this dissertation were inspired by the intriguing idea that neurons are 
not solely responsible for conveying sensory information from peripheral tissues. Non-neuronal 
cells of target tissues also have a significant role in sensory signaling, as studies from the skin and 
bladder epithelium have shown (Baumbauer et al., 2015; Maksimovic et al., 2014; Pang et al., 
2015; Winder et al., 2014). In the colon, epithelial lining cells express many of the membrane 
receptors involved in detection of mechanical and chemical stimuli found in sensory neurons, 
suggesting a direct role in monitoring the contents of the gut lumen (see Figure 1). As they also 
release neuroactivators such as ATP, 5-HT and glutamate, they have long been implicated as 
modulators of neural activity but inconclusively shown to act in a direct manner. My work has 
addressed this challenging question. Chapter 1 details how optogenetic activation of the colon 
epithelium initiates action potential firing in extrinsic primary afferent neurons (ExPANs), which 
send sensory information from the colon to neurons in the central nervous system. Visceromotor 
response (VMR) experiments showed that this activation results in nociceptive responses in vivo. 
In Chapter 2, I have shown that optogenetic inhibition of the colon epithelium attenuated these 
nociceptive responses and that inhibition of epithelial cells is effective in reducing inflammation-
induced visceral hypersensitivity. 
These experiments were also inspired by growing interest in the gut-brain axis. Not only 
are disorders of the gut such as IBS and IBD prevalent, but there is increasing evidence that gut-
brain interactions have a role in “non-GI” diseases. These include depression, autism, diabetes, 
and Parkinson’s, suggesting that colon health has an important role for whole-body homeostasis 
(Bessac et al., 2018; Chalazonitis & Rao, 2018; Dinan & Cryan, 2017). To understand these gut-
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brain connections, it is critical to mechanistically define how the gut detects sensory stimuli, 
transmits these signals to the ENS and CNS and in so doing, maintains proper gut motility. The 
epithelium is at the forefront of this sensory cascade, as it interacts with all luminal contents, which 
includes the microorganisms comprising the gut microbiome (Dinan & Cryan, 2017). Towards 
understanding this complex interaction, Chapter 3 describes studies that show that activation of 
the epithelium can lead to activation of ENS neurons and in so doing, initiate colon motility. 
5.1 Role of the Colon Epithelium in Visceral Nociception 
Studies of Chapter 1 showed that optogenetic activation of the colon epithelium in villin-
ChR2 mice engages neural circuitry involved in conveying sensory information from the colon to 
the central nervous system. Studies performed in an ex vivo colon-nerve preparation show that 
ChR2-mediated activation of the epithelium initiates action potential (AP) firing in colon ExPANs. 
This ExPAN activity had a functional result, as epithelial stimulation also resulted in visceral 
nociceptive responses in vivo. The neuronal responses to light stimulation of epithelial cells could 
be blocked with ATP (purinergic) receptor antagonists, in most ExPANs that were interrogated. 
ExPAN responses to epithelial activation were similar to those elicited by mechanical 
stimulation (probing, brushing, and stretching of the colon tissue). They were also comparable to 
blue light-mediated responses when ChR2 was expressed in the ExPANs themselves (under the 
TRPV1 promoter). However, there was a latency between ChR2-mediated epithelial activation 
and ExPAN firing, ranging from 0.03 – 60 s, suggesting that epithelial cells could communicate 
with ExPANs via several mechanisms. Transmission from epithelial cells may be diffuse and have 
slow and indirect action on colon ExPAN terminals. Long latencies may be explained by the 
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location of the ExPAN terminal, i.e., ExPANS with nerve terminals in the serosal layer (distant 
from the mucosa) may have a longer latency to epithelial-induced firing than those with terminals 
in the submucosal layer. Anatomical locations of functionally classified ExPANs (mucosal, 
muscular, muscular/mucosal, serosal) have not been totally defined (Brierley et al., 2018). Thus, 
it is difficult at this time to define mechanistic links between epithelial cells and AP firing in 
specific ExPAN types. Intermediary cell types, such as intrinsic neurons and immune cells, may 
also have a role where neurotransmitters released from the epithelium may act on ExPANs, which 
could explain the long latencies.  
On the other hand, some epithelial-induced ExPAN responses may have been mediated 
through a more direct connection. Studies show that communication from enteroendocrine cells 
(EECs) in the epithelium to colon ExPANs may be achieved through direct synaptic transmission 
(Kaelberer et al., 2018), which may have been reflected in our studies, particularly when ExPAN 
latency to firing was in the millisecond time range. EECs in the colon are rare, comprising only 
1% of the total epithelial cell population (Bertrand, 2009). Thus, it is possible that the varied 
ExPAN firing latencies seen in our studies were a reflection of the composition of epithelial cells 
in a given receptive field. Shorter latencies may have been due to the percentage of EECs in the 
blue light-activated field, whereas longer latencies were due to fields with enriched enterocytes, 
which likely have a modulatory role in ExPAN activity than a direct role. This variability was also 
reflected in the behavioral experiments, where optogenetic activation of the epithelium did not 
always elicit a VMR, e.g., the response rate in Vil-ChR2 mice was 78%, compared to nearly 100% 
in TRPV1-ChR2 mice.  
The longer latencies in most cases of epithelial-induced ExPAN firing also suggested 
involvement of a chemical mediator. We found that addition of ATP receptor antagonists to the 
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colon-nerve prep blocked ExPAN responses to epithelial stimulation in most cases. This finding 
supports the purinergic hypothesis proposed in previous studies, in which intestinal epithelial cells 
release endogenous ATP in response to distension stimuli in the colon, which then acts on P2X 
and P2Y receptors on ExPAN terminals (Burnstock, 1999, 2001, 2013; Wynn et al., 2004; Wynn 
et al., 2003). These studies used non-specific activation of epithelial cells, however, since colon 
distension activates all mechanosensitive cells outside of the epithelium as well. Our study enabled 
activation of epithelial cells in the absence of any mechanical or chemical stimuli, confirming the 
ability of epithelial-derived ATP to activate ExPANs. 
To summarize Chapter 2, activating the epithelium alone, without addition of mechanical 
stimuli, initiated ExPAN firing in an ATP-dependent manner. These findings suggest that 
epithelial cells have a significant influence on the activity of colon ExPANs and resulting 
nociceptive signaling. With evidence of a direct role in pain signaling, it is also possible that the 
epithelium contributes to the ExPAN sensitization involved in visceral hypersensitivity. In Chapter 
3, I hypothesized that inhibition of the colon epithelium would attenuate nociceptive signaling and 
inflammatory hypersensitivity. 
In studies of Chapter 3, I used the villin gene promoter to target the inhibitory yellow light-
activated archaerhodopsin (Arch) protein to colon epithelial cells. I used an established VMR 
protocol to assess colon sensitivity to a noxious distension stimulus (60 mmHg balloon distension) 
with and without yellow light illumination of the colon lumen. Arch-mediated inhibition of colon 
epithelial cells diminished visceral nociceptive responses in healthy mice. Yellow light was 
effective in approximately 50% of distension + laser trials, and in the trials that produced an effect, 
light-mediated inhibition of the epithelium diminished VMRs to distension by over 60%. With 
directly inhibition of ExPANs (in TRPV1-Arch animals), yellow light was effective in reducing 
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the VMR by nearly 85%. Of note, TRPV1-Arch animals tended to show more consistent responses 
to yellow light (VMR was inhibited in an average of 75% of trials) compared to the epithelium. 
The inconsistent efficacy of inhibiting the epithelium further suggests a modulatory role for the 
epithelium in nociceptive signaling. 
After testing the effects of yellow light-mediated epithelial inhibition in healthy mice, I 
then investigated the effects of epithelial and ExPAN inhibition in the dextran sulfate sodium 
(DSS) model of inflammation, which is commonly used in mouse studies to mimic inflammatory 
bowel disease. DSS induced marked visceral hypersensitivity, which was effectively reduced by 
light-mediated inhibition of the epithelium. This inhibition was not as effective in the inflamed 
colon however; in naïve mice, Arch-mediated epithelial inhibition reduced the VMR by 80%, 
whereas in DSS-treated mice, it reduced the VMR by 50%. Arch-mediated inhibition of ExPANs 
in the DSS-treated mice was also effective at reducing hypersensitivity, to a similar extent as 
epithelial inhibition. The ability of epithelial inhibition to reduce nociceptive responses and 
visceral hypersensitivity suggest the epithelial lining is an important component of nociceptive 
signaling pathways.  
5.1.1  Experimental Limitations 
The optogenetic techniques employed in the described studies enabled specific activation 
and inhibition of the colon epithelium and colon ExPANs. It has historically been difficult to 
investigate the epithelial contribution to neuronal activity due to the intimate association of nerve 
terminals and the epithelium. For example, addition of chemical or mechanical stimulation to the 
colon stimultaneously activates the epithelium and nerves, making the relative contribution of each 
cell type undecipherable. Light-mediated activation and inhibition of the colon epithelium was 
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enabled by opsin gene expression under regulation of the mouse villin gene promoter. In this 
system ChR2 or Arch is expressed in all colon epithelial cell types. These diverse cell types likely 
have different roles in sensory signaling. The most obvious example is that EECs are electrically 
excitable and can form direct synaptic connections with surrounding neurons. In contrast, while 
enterocytes can release ATP and other molecules relevant to sensory signaling, they likely do so 
in a slower manner, having more of a modulatory influence on surrounding neurons. Use of the 
villin-Cre driver to target ChR2 and Arch did not allow a discrimination of which epithelial 
subpopulation mediated the effects of light stimulation. Another consideration is that the TRPV1-
cre driver used to express ChR2 and Arch in colon ExPANs is not entirely specific to TRPV1-
expressing neurons in the adult mouse. TRPV1 is transiently expressed in many developing 
neurons and becomes restricted to a smaller population in the adult mouse. Use of TRPV1-cre 
therefore targets neurons outside of the adult TRPV1 population (Cavanaugh, Chesler, Braz, et al., 
2011; Hjerling-Leffler, Alqatari, Ernfors, & Koltzenburg, 2007). This is likely a minor issue 
however, since the vast majority of colon ExPANs in the adult mouse express TRPV1 (S. A. Malin 
et al., 2009). 
There are additional experimental limitations concerning the use of optogenetics. One 
consideration is that ChR2 is a large protein and it is not completely understood how expression 
of the protein itself can affect normal cellular processes. It is also unclear how light activation of 
opsin expressing cells can affect their function; for example, it is possible that cells inhibited via 
Arch activation could produce an exaggerated rebound response after removal of yellow light, 
meaning some results could be caused by excitation, rather than inhibition of those cells (Bernard, 
2020). Lastly, there could be unexpected consequences of light stimulation itself, such rises in 
temperature, which could affect cell functions (e.g., enzymatic reactions) (Tyssowski & Gray, 
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2019). Although we did not detect any broad temperature changes in colon tissue, there could have 
been smaller, more localized changes that can affect cellular functions. 
Another experimental limitation is the use of optogenetics in non-neuronal cells. Colon 
epithelial cells, with the exception of EECs, are not electrically excitable, making it difficult to 
determine the effect of opsin activation on their endogenous signaling. For example, it has been 
determined that ChR2 activation in neurons depolarizes the membrane and causes activation of 
voltage gated Na+ channels and action potential firing. Although ChR2-mediated membrane 
depolarization does occur in non-neuronal cells like keratinocytes and colon epithelium, the effects 
of this depolarization have not been defined (Baumbauer et al., 2015; Moehring et al., 2018). Based 
on our pharmacological studies, ATP is a possible factor released in response to ChR2-mediated 
depolarization. However, numerous attempts to obtain consistent measure of ATP in colon cells 
activated by light stimuli have been exceptionally difficult. Similarly, opsin-mediated inhibition is 
likely not the same in neuronal and non-neuronal cells. For example, Arch expression in neurons 
enables membrane hyperpolarization and prevents AP firing (Chow et al., 2010). The effect of 
hyperpolarization in an epithelial cell very likely has a different effect than Arch-mediated 
inhibition of neurons. 
A final experimental consideration is the variability of the VMR experimental assay, where 
measures obtained using simultaneous balloon distension and yellow light stimulation proved to 
be inconsistent (Chapter 2). A likely reason for this inconsistency is the presence of luminal 
contents that could block or reduce the power of blue or yellow light reaching the epithelium. This 
illustrates an issue that will need to be addressed if opsins are to be a therapeutic possibility for 
treatment of diseases of the gut. 
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5.1.2  Future Directions 
Data discussed in the previous sections support the hypothesis that the combination of all 
epithelial cell types is necessary for normal sensation in the colon, and also highlight the need for 
further studies. To determine the contribution of each cell type to sensory signaling, it will be 
imperative to develop cell type-specific manipulation paradigms applicable to colon physiology, 
for instance via optogenetics and chemogenetics. The most obvious cellular targets that should be 
interrogated are EECs, since they can form synapses with surrounding neurons and are electrically 
excitable (Alcaino et al., 2018; F. Wang et al., 2017). Enterochromaffin cells (ECs) are one type 
of EEC that show evidence of these synapses. Importantly, they express the receptors TRPA1 and 
Piezo2, which are critical in mechanosensation and pain signaling (Alcaino et al., 2018; Bellono 
et al., 2017). This receptor expression profile and connectivity with surrounding colon ExPANs 
may indicate that ECs have a more salient role in sensory signaling than other cell types. As such, 
it will be important to determine which functional classes of ExPANs most frequently synapse 
with EECs. Additionally, towards the goal of determining which colon epithelial cell types mediate 
visceral pain signaling, comprehensive studies are needed to identify all sensory receptors 
expressed in each cell type, similar to the single-cell RNAseq analysis of small intestine epithelium 
(Haber et al., 2017).  
Studies in Chapter 1 demonstrated the role of ATP in colon epithelial-neuronal signaling, 
but purinergic receptor antagonists did not completely block the epithelial-induced ExPAN firing, 
indicating involvement of other neurotransmitters. Additionally, these studies employed 
antagonist cocktails for P2X and P2Y receptors expressed on ExPANs, falling short of defining 
purinergic receptors most critical to epithelial-ExPAN signaling. Future studies should examine 
the role of other epithelial-released molecules, such as neuropeptides, in modulation of colon 
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ExPAN activity. Functional analysis of specific colon ExPAN receptors is also needed to 
determine which receptors are important in epithelial-neural signaling. An obvious candidate is 5-
HT, as studies have begun to show with specificity that 5-HT released from ECs can act on 5-HT3 
receptors expressed on ExPANs (Bellono et al., 2017). However, these studies did not include a 
behavioral assay to confirm the role of EC-ExPAN interactions in visceral nociception.  
Lastly, different optogenetic techniques should be employed to circumvent the issue of 
luminal contents in the colon blocking laser access to target cells. One tool that should be tested is 
a wireless cuff that can locally deliver laser stimuli by wrapping around the outside of the organ 
(Mickle & Gereau, 2018; Samineni et al., 2017). This local laser modulation of sensory signaling 
could be effective since it is apparent from colon motility studies that light stimulation can 
penetrate the colon wall and reach the epithelium (Hibberd, Feng, et al., 2018). If optogenetics 
actually become a viable therapeutic option, light will be most likely be delivered via small 
electrodes rather than a long fiber optic. Thus, it is important to begin validation of these wireless 
cuffs as tools for regulation of colon function. 
5.2 Role of the Colon Epithelium in Gut Motility 
After demonstrating that the colon epithelium initiates activity in ExPANs, I sought to 
examine the role of the epithelium in intrinsic sensory signaling. Intrinsic primary afferent neurons 
(IPANs) of the ENS terminate in the mucosal layer and are responsible for initiating ENS motor 
reflexes in response to luminal stimuli (Furness, Robbins, et al., 2004). Although these nerve 
endings are closely associated with the epithelium (see Figure 2), it is unclear how essential colon 
epithelial cells are in conveying sensory information to initiate these reflexes. In the experiments 
 109 
in Chapter 4, I employed optogenetic techniques to enable ChR2-mediated activation of colon 
epithelial cells and monitored myenteric neuronal activity using genetically encoded Ca2+ 
indicators. Given their ability to release neurotransmitters, I predicted that optogenetic activation 
of colon epithelial cells would result in measurable responses in myenteric neurons.  
Results showed that colon epithelial cells induce neuronally-mediated changes in gut 
motility, most likely through purinergic signaling. Epithelial stimulation initiated Ca2+ activity in 
myenteric neurons in the distal colon, which was strong enough to produce a functional outcome, 
evidenced by local colon motility. My studies suggest that ATP, and possibly 5-HT, underlie the 
local epithelial-evoked movement we observed. Additionally, in full-length, closed colon 
preparations, epithelial activation in the distal colon increased the rate of rhythmic colonic 
migrating motor complexes (CMMCs) initiated in the proximal colon, indicating that the colon 
epithelium has the potential to influence large-scale coordination of ENS activity. 
These epithelial-ENS communication studies displayed several parallels to the discoveries 
from Chapter 1. Importantly, there was a latency between epithelial activation and myenteric 
neuronal responses, likely explained by the release of neuroactive chemicals from the epithelium 
which then have to reach IPAN nerve terminals. The latency to response ranged from 2 – 16 s and 
the average latency was 6.5 s. As expected, this latency was longer than localized electrical 
stimulation of the colon (average 0.13 s). The latency between epithelial activation and colon 
movement was slightly longer (average 7.7 s), indicating that myenteric neuron activation 
preceded colon movement. This suggests that the epithelium is directly involved in initiating 
sensory-motor reflexes in the ENS. In the epithelial-ExPAN studies in Chapter 1, the ExPANs also 
displayed a latency to response after epithelial activation, averaging around 15 s. Although a 
different technique was used to record ExPAN activation (extracellular teased-fiber recordings), it 
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is still evident that these average latencies were longer than myenteric activation. This could 
indicate that epithelial-ExPAN communication relies on intermediate cell types; it is possible that 
ExPAN responses are due to local changes in motility induced by the epithelial-initiated sensory-
motor response. In Chapter 1, the functional consequence of ExPAN activation was the nociceptive 
responses observed in VMR experiments. The latency to VMR in response to blue light 
illumination of the colon lumen was actually shorter than the average latency to ExPAN firing 
(average of only 8 s). However, these experiments involved a wider distribution of laser 
stimulation, which may have simultaneously activated more ExPANs than the localized 
stimulation in the ex vivo prep, thus leading to a quicker response. 
The studies in Chapters 1 and 3 indicate that epithelial-induced activation of the ENS 
usually occurs before ExPAN activation, suggesting that changes in gut motility can impact 
extrinsic sensory signaling from the colon to the CNS. However, ExPAN activation has reciprocal 
effects on the ENS. Another study from our lab showed that ExPAN activation initiates a spinal 
cord reflex where parasympathetic neurons are triggered to act on myenteric neurons and produce 
colon contractions (Smith-Edwards et al., 2019). This circuit demonstrates how visceral pain and 
colon motility are linked, which is important to understand since many disorders like IBS and IBS 
feature visceral pain as well as disordered colon motility. Taken together, these studies reveal the 
complexity of interactions between the colon epithelium and the intrinsic and extrinsic innervation 
of the colon.  
5.2.1  Experimental Limitations 
The use of optical techniques and imaging (ChR2 opsins and GECIs) in Chapter 4 enabled 
simultaneous activation of the colon epithelium and monitoring of neurons in the myenteric plexus. 
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It was previously a challenge to record activity of ENS neurons in situ during epithelial activation 
because electrophysiological recording in the myenteric plexus requires removal of the epithelium 
and submucosal layer (Bertrand, 2003). Although these optical tools provide unprecedented 
control of specific cell activation, there are a number of caveats, some of which were mentioned 
in 5.1.1 And as previously mentioned, the use of the villin promoter resulted in expression of ChR2 
in all epithelial cell types, making it impossible for us to know which cell types were exerting the 
described actions on the ENS neurons.  
Myenteric neuron activity was recorded using red-shifted GECIs and, as it is well-known, 
Ca2+ is only a proxy for neuronal activity. GECIs do not provide the same single-spike resolution 
as intracellular recordings, although they provide more accessible means to monitor entire 
populations of neurons in situ (Akerboom et al., 2013; T. W. Chen et al., 2013; Smith-Edwards et 
al., 2016; Tian et al., 2012). Green-fluorescent GECIs like GCaMP are more commonly used to 
measure neuronal activity but could not be used in this study because the blue excitation for green 
GECIs also activates ChR2. Red-shifted GECIs require a green excitation light, enabling us to 
image the myenteric plexus while using blue light to activate ChR2-expressing epithelial cells. 
Unfortunately, red-shifted GECIs, including the jRCaMP1b and jRGECO1a variants used here, 
are not as sensitive to Ca2+ compared to GCaMP6s (Dana et al., 2016). However their sensitivity 
is are sufficient to report spontaneous activity and evoked responses in many myenteric neurons, 
albeit at lower numbers (Smith-Edwards et al., 2019). With this caveat, it is likely that the neural 
activation observed in response to laser stimulation of the epithelium is an underrepresentation. 
In addition to the limitations presented by the optical tools used in Chapter 4, the 
pharmacological methods used could be refined. Cocktails of ATP and 5-HT receptor antagonists 
were used to determine whether these neurotransmitters mediated the epithelial-myenteric neuron 
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communication. Although ATP receptor antagonists were able to block epithelial-induced local 
contractions, a major caveat is that ATP signaling also occurs between ENS neurons in descending 
pathways (Burnstock, 2014) and in neuron-glia communication (Gulbransen & Sharkey, 2009), so 
the use of these antagonists may have blocked colon motility independent of epithelial signaling. 
5.2.2  Future Directions 
Future experiments should employ optogenetic and/or chemogenetic techniques to define 
which specific epithelial cell types contribute to myenteric neuron activity and ENS reflexes. More 
defined optical techniques should also be used to specify which populations of myenteric neurons 
(IPANs, interneurons, or motor neurons) are being monitored in Ca2+ imaging studies. EC cells 
should be targeted first, as they are the main producer of 5-HT in the gut and it is hotly debated 
whether endogenous release from these cells is essential to colon motility. My results using 5-HT 
antagonists to block epithelial-induced local contractions were inconclusive and this may be due 
to the possibility that 5-HT may be more important in regulating CMMCs, which occur on the 
order of minutes, than in mediating localized colon contractions occurring only seconds after 
epithelial stimulation. Therefore, 5-HT antagonists should be utilized in whole-colon motility 
studies where ChR2-mediated activation of the distal colon epithelium. Further, more specific 
pharmacology should be used for ATP and 5-HT signaling to expand upon my results using 
antagonist cocktails.  
Optical techniques for interrogating ENS circuits should continue to be developed. In these 
studies, red-shifted GECIs were expressed in ENS neurons to enable simultaneous blue light 
activation of ChR2, but these Ca2+ indicators are not as efficient as GCaMP6 (Smith-Edwards et 
al., 2019). GCaMP6 enabled imaging of robust spontaneous activity in the myenteric plexus, 
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whereas RCaMP and RGECO detected spontaneous activity in a much lower percentage of 
myenteric neurons. Therefore, it should be determined whether the combination of red-shifted 
ChR2 and GCaMP6s (the reverse of what is used in Chapter 4) is more useful for investigating 
intercellular activity. Electrophysiological studies should be performed in myenteric neurons to 
define how GCaMP6 and red-shifted GECIs approximate neuron AP firing. Additionally, optical 
tools can be used to measure interactions between other cells types and ENS neurons. Other non-
neuronal cell types that are involved in ENS function include enteric glia, immune cells, and 
interstitial cells of Cajal (Furness, 2012; Smith-Edwards et al., 2019). Optical techniques can be 
employed to better understand how these different cell types work together to maintain colon 
health and homeostasis. 
5.3 Colon Epithelial-Neuronal Signaling in Pathological Conditions 
 
Acute and chronic inflammation likely affect epithelial-neuronal signaling in the colon, 
and more studies are required to examine how alterations at this interface affect disease processes 
and symptoms. One possibility is that, like neurons, epithelial cells become hypersensitive with 
inflammation, thus amplifying the sensory signaling pathways. This could occur via inflammation-
induced changes in voltage-sensitive channels that regulate electrically excitable epithelial cell 
types (such as ECs) and/or via changes in proteins that regulate exocytosis/release of neuroactive 
substances. Another important consideration is whether these changes persist after turnover of the 
epithelium. Evidence has shown that the colon epithelium, including EECs, is replenished every 5 
days (Tsubouchi & Leblond, 1979). However, a more recent study showed that a subpopulation of 
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EECs could persist for 60 days (Bohorquez et al., 2015). Studies of the bladder epithelium have 
shown that injury can evoke long-term changes in epithelial signaling properties (Gupta et al., 
2009). It will be interesting to see whether this is true for different subtypes of colon epithelial 
cells. Some research shows that inflammation can affect the abundance and neurotransmitter 
content of EECs in the colon after inflammation, but more thorough analyses are required to assess 
changes at the cellular level. Using GCaMP imaging I have begun to assess changes in spontaneous 
Ca2+ activity induced by colon inflammation. Interestingly, significant increases in spontaneous 
Ca2+ activity are observed in the epithelium 1 week after DSS treatment. Future studies will assess 
evoked Ca2+ activity and how inflammation impacts specific epithelial cell types.  
 
Figure 21. Spontaneous Ca2+ activity in the colon epithelium increases after DSS inflammation. 
GCaMP6 was expressed in under the villin promoter to enable Ca2+ imaging of the colon epithelium. Mice were given 
vehicle or DSS treatment and preliminary studies show that spontaneous Ca2+ activity in vehicle-treated mice (A) was 
lower than DSS-treated mice (B), 7 days after DSS treatment. C) Spontaneous Ca2+ activity was quantified as active 
cells per crypt and significant increases were observed after DSS treatment. 
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In future studies of epithelial-neuronal communication, multiple animal models that elicit 
the hallmarks of colon diseases with different etiology should be employed (e.g., DSS or 
trinitrobenzene sulfonic acid (IBD), zymosan or repeated stress (IBS), and parasite infection 
models) to assess the full range of epithelial responses to different disease challenges. A thorough 
analysis of epithelial changes will require multimodal strategies including calcium imaging and 
electrophysiology techniques, high resolution anatomical analysis (e.g., 3D electron microscopic 
reconstruction) as well as neurotransmitter release assays. This comprehensive approach is 
required to fully understand the complexity of epithelial-nerve interactions. Considering the 
impact of epithelial-neuronal communication in nociceptive signaling and gut motility, studying 
these interactions will provide valuable insight into why visceral pain is often co-morbid with 
dysmotility.  
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